<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9570651</article-id><article-id pub-id-type="pmid">36234921</article-id><article-id pub-id-type="doi">10.3390/molecules27196387</article-id><article-id pub-id-type="publisher-id">molecules-27-06387</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Biosynthesis of DNA-Alkylating Antitumor Natural Products</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2805-1462</contrib-id><name><surname>Nie</surname><given-names>Qiu-Yue</given-names></name><xref rid="af1-molecules-27-06387" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Yu</given-names></name><xref rid="af1-molecules-27-06387" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Xian-Feng</given-names></name><xref rid="af1-molecules-27-06387" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Gong-Li</given-names></name><xref rid="af1-molecules-27-06387" ref-type="aff">1</xref><xref rid="af2-molecules-27-06387" ref-type="aff">2</xref><xref rid="c1-molecules-27-06387" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Csuk</surname><given-names>Ren&#x000e9;</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-27-06387"><label>1</label>State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China</aff><aff id="af2-molecules-27-06387"><label>2</label>School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, 1 Sub-lane Xiangshan, Hangzhou 310024, China</aff><author-notes><corresp id="c1-molecules-27-06387"><label>*</label>Correspondence: <email>gltang@sioc.ac.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2022</year></pub-date><volume>27</volume><issue>19</issue><elocation-id>6387</elocation-id><history><date date-type="received"><day>31</day><month>8</month><year>2022</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>DNA-alkylating natural products play an important role in drug development due to their significant antitumor activities. They usually show high affinity with DNA through different mechanisms with the aid of their unique scaffold and highly active functional groups. Therefore, the biosynthesis of these natural products has been extensively studied, especially the construction of their pharmacophores. Meanwhile, their producing strains have evolved corresponding self-resistance strategies to protect themselves. To further promote the functional characterization of their biosynthetic pathways and lay the foundation for the discovery and rational design of DNA alkylating agents, we summarize herein the progress of research into DNA-alkylating antitumor natural products, including their biosynthesis, modes of action, and auto-resistance mechanisms. </p></abstract><kwd-group><kwd>biosynthesis</kwd><kwd>DNA alkylating agents</kwd><kwd>antitumor natural products</kwd><kwd>resistance</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>31930002</award-id><award-id>21621002</award-id></award-group><award-group><funding-source>Youth Innovation Promotion Association Chinese Academy of Sciences</funding-source><award-id>2019257</award-id></award-group><funding-statement>National Natural Science Foundation of China (31930002 and 21621002) and the Youth Innovation Promotion Association Chinese Academy of Sciences (2019257).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-27-06387"><title>1. Introduction</title><p>Natural products (NPs) are an important source of pharmaceuticals due to their diverse bioactivities [<xref rid="B1-molecules-27-06387" ref-type="bibr">1</xref>]. Since DNA is essential for living organisms, DNA-targeting NPs, which usually function as carcinogenesis or cancer treatment, constitute an indispensable family of bioactive NPs [<xref rid="B2-molecules-27-06387" ref-type="bibr">2</xref>,<xref rid="B3-molecules-27-06387" ref-type="bibr">3</xref>]. Although the genotoxic metabolite colibactin, produced by human gut bacteria, is shown to cause colorectal cancer by alkylating DNA to generate DNA mutation [<xref rid="B4-molecules-27-06387" ref-type="bibr">4</xref>,<xref rid="B5-molecules-27-06387" ref-type="bibr">5</xref>,<xref rid="B6-molecules-27-06387" ref-type="bibr">6</xref>], some DNA-targeting NPs are applied in chemotherapy. They can interact with specific DNA duplex structures and cause DNA damage via different modes of action [<xref rid="B7-molecules-27-06387" ref-type="bibr">7</xref>]. One of the mechanisms is the cleavage of DNA through inducing the production of radical DNA by redox reactions or nucleophilic addition. Broad anti-cancer antibiotic bleomycin (BLM) can be transformed to HOO-Fe(III)-BLM in the presence of Fe/O<sub>2</sub> to damage DNA [<xref rid="B8-molecules-27-06387" ref-type="bibr">8</xref>]. The enediyne-containing NPs dynemicin A and calicheamicin can generate biradical intermediates to cleave DNA activated by reducing the quinone moiety and the attack of a thiol, respectively [<xref rid="B9-molecules-27-06387" ref-type="bibr">9</xref>,<xref rid="B10-molecules-27-06387" ref-type="bibr">10</xref>,<xref rid="B11-molecules-27-06387" ref-type="bibr">11</xref>,<xref rid="B12-molecules-27-06387" ref-type="bibr">12</xref>]. Some chemicals, such as streptozotocin, conduct the methylation of DNA [<xref rid="B13-molecules-27-06387" ref-type="bibr">13</xref>,<xref rid="B14-molecules-27-06387" ref-type="bibr">14</xref>]. Additionally, another family of DNA-targeting antitumor agents can alkylate DNA in situ with covalent bonds. They can directly react with DNA using highly active functional groups such as epoxide, cyclopropane, and aziridine to form bulky DNA adducts [<xref rid="B15-molecules-27-06387" ref-type="bibr">15</xref>,<xref rid="B16-molecules-27-06387" ref-type="bibr">16</xref>]. Furthermore, as a result of the potent cytotoxicity of DNA-alkylating NPs, it is preferable for their producers to possess resistant genes located in biosynthetic gene clusters (BGCs) to protect themselves. BGCs-associated self-resistance is mainly achieved through excision of the abnormal base, degradation of active functional groups, and the binding or transport of toxins [<xref rid="B17-molecules-27-06387" ref-type="bibr">17</xref>]. </p><p>The biosynthesis and resistance of radical-based DNA damage agents, including BLMs and enediynes, have already been well reviewed [<xref rid="B18-molecules-27-06387" ref-type="bibr">18</xref>]; herein, we mainly discuss DNA-alkylating (except DNA-methylation) antitumor NPs, including their modes of action, BGC-associated self-resistance, and biosynthetic pathways, especially the construction of their highly active groups as a warhead. </p></sec><sec id="sec2-molecules-27-06387"><title>2. Spirocyclopropane-Containing Cyclohexadienone Natural Products</title><p>The spirocyclopropylcyclohexadienone family, including yatakemycin (YTM, <bold>1</bold>), CC-1065 (<bold>2</bold>), and duocarmycin SA (<bold>3</bold>), all contain a highly active cyclopropane moiety and exhibit potent antitumor activities (<xref rid="molecules-27-06387-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B19-molecules-27-06387" ref-type="bibr">19</xref>,<xref rid="B20-molecules-27-06387" ref-type="bibr">20</xref>,<xref rid="B21-molecules-27-06387" ref-type="bibr">21</xref>,<xref rid="B22-molecules-27-06387" ref-type="bibr">22</xref>]. Duocarmycin-based antibody-drug conjugates (ADC, SYD985 (<bold>4</bold>), and MDX-1203 (<bold>5</bold>)) have entered clinical trials for the treatment of specific cancers as prodrugs (<xref rid="molecules-27-06387-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B23-molecules-27-06387" ref-type="bibr">23</xref>,<xref rid="B24-molecules-27-06387" ref-type="bibr">24</xref>]. They can selectively bind AT-rich regions in the DNA minor groove by non-covalent interaction, then form a covalent bond with DNA in which the cyclopropanol group is attacked by the N-3 of adenine (<xref rid="molecules-27-06387-f002" ref-type="fig">Figure 2</xref>A) [<xref rid="B25-molecules-27-06387" ref-type="bibr">25</xref>]. The YTM-producer was first identified as protecting itself with DNA glycosylases YtkR2 through the base-excision repair mechanism (<xref rid="molecules-27-06387-f002" ref-type="fig">Figure 2</xref>A). The homologous enzyme C10R5 exhibited a similar function in the CC-1065-producing strain. [<xref rid="B26-molecules-27-06387" ref-type="bibr">26</xref>] Because the cyclopropane warhead exhibits strong potency, additional self-protection of their hosts can also be achieved by the cleavage of this moiety. A GyrI-like protein was verified to hydrolyze the cyclopropane moiety in YTM and CC-1065 to facilitate detoxification (<xref rid="molecules-27-06387-f002" ref-type="fig">Figure 2</xref>B) [<xref rid="B27-molecules-27-06387" ref-type="bibr">27</xref>,<xref rid="B28-molecules-27-06387" ref-type="bibr">28</xref>,<xref rid="B29-molecules-27-06387" ref-type="bibr">29</xref>]. </p><p>The benzodipyrrole scaffold in CC-1065 was derived from serine, methionine, and tyrosine-derived DOPA, and was revealed by isotopic feeding experiments (<xref rid="molecules-27-06387-f003" ref-type="fig">Figure 3</xref>) [<xref rid="B30-molecules-27-06387" ref-type="bibr">30</xref>,<xref rid="B31-molecules-27-06387" ref-type="bibr">31</xref>]. Wu et al. proposed the possible biosynthetic pathway of CC-1065. Tyrosine was first oxidized to DOPA which underwent intramolecular cyclization to afford <bold>10</bold>. Next, <bold>11</bold> produced by the combination of serine and <bold>10</bold> was decarboxylated and cyclized to yield <bold>13</bold> which was further modified to form three different types of building blocks (<bold>17</bold>, <bold>18</bold>, and <bold>19</bold>). The assembly of these building blocks generated the final core structure <bold>21</bold> (<xref rid="molecules-27-06387-f004" ref-type="fig">Figure 4</xref>).</p><p>Strategies for the incorporation of cyclopropane have long fascinated chemists, since it is an important synthetic building block and a common pharmacophoric group. The chemical synthesis of cyclopropane in this family of NPs was mainly achieved by nucleophilic cyclopropanation [<xref rid="B32-molecules-27-06387" ref-type="bibr">32</xref>]. In the biosynthesis of CC-1065, Jin et al. reported that a two-component cyclopropanase system consisting of a HemN-like radical S-adenosylmethionine (SAM) enzyme C10P and a methyltransferase C10Q was responsible for generating the essential cyclopropane moiety involving a unique enzymatic mechanism (<xref rid="molecules-27-06387-f005" ref-type="fig">Figure 5</xref>) [<xref rid="B33-molecules-27-06387" ref-type="bibr">33</xref>,<xref rid="B34-molecules-27-06387" ref-type="bibr">34</xref>]. To explain in detail, the highly active SAM methylene radical attacks the C-11 position of <bold>22</bold> to generate the radical intermediate <bold>23</bold>, which subsequently abstracts hydrogen to yield the SAM-substrate adduct <bold>24</bold>. Following this, the deprotonation of the phenolic hydroxyl group in virtue of His-138 residue in C10Q induced S<sub>N</sub>2 cyclopropanation to produce CC-1065 with S-adenosylhomocysteine (SAH) as the leaving group. Additionally, <bold>24</bold> could also be converted to <bold>25</bold> by non-enzymatic reaction with the release of SAH, and the following isomerization produces the methylated compound <bold>26</bold>.</p></sec><sec id="sec3-molecules-27-06387"><title>3. DNA-Alkylating Natural Products with Heterocyclic Propane as Pharmacophore</title><sec id="sec3dot1-molecules-27-06387"><title>3.1. Pluramycins</title><p>As an important family of NPs, type II polyketides display various structurally diverse biological activities [<xref rid="B35-molecules-27-06387" ref-type="bibr">35</xref>,<xref rid="B36-molecules-27-06387" ref-type="bibr">36</xref>]. Anthracycline compounds such as daunomycin and nogalamycin exhibit antitumor activities by intercalating into grooves of DNA, while most of these compounds are unable to form a covalent bond with duplex DNA [<xref rid="B37-molecules-27-06387" ref-type="bibr">37</xref>,<xref rid="B38-molecules-27-06387" ref-type="bibr">38</xref>]. Nevertheless, pluramycin antibiotics including hedamycin (<bold>27</bold>) and altromycin B (<bold>28</bold>) (<xref rid="molecules-27-06387-f006" ref-type="fig">Figure 6</xref>A), which usually contain an epoxide moiety, can intercalate and alkylate DNA simultaneously. Similar to daunomycin, their anthraquinone ring was characterized as intercalating into DNA and binding saccharides in the minor or major groove, thereby contributing to the stabilization of the drug&#x02013;DNA complex [<xref rid="B39-molecules-27-06387" ref-type="bibr">39</xref>,<xref rid="B40-molecules-27-06387" ref-type="bibr">40</xref>,<xref rid="B41-molecules-27-06387" ref-type="bibr">41</xref>]. Furthermore, their epoxides could be opened via nucleophilic attack of N-7 of guanine, resulting in the formation of an adduct by covalent bond (<xref rid="molecules-27-06387-f006" ref-type="fig">Figure 6</xref>B).</p><p>Biosynthetically, the epoxides in hedamycin were formed on its non-acetyl starter unit generated by two separate type I polyketide synthases (PKSs, HedT, and HedU). HedU was proposed to catalyze two rounds of chain elongation employing the acetyl starter unit provided by HedT (<xref rid="molecules-27-06387-f007" ref-type="fig">Figure 7</xref>) [<xref rid="B42-molecules-27-06387" ref-type="bibr">42</xref>,<xref rid="B43-molecules-27-06387" ref-type="bibr">43</xref>,<xref rid="B44-molecules-27-06387" ref-type="bibr">44</xref>]. The obtained unsaturated 2,4-hexadienyl unit was then transferred to the downstream type II PKS to produce the aromatic precursor. The following oxidation of the C2-alkyl side in intermediate <bold>30</bold> afforded the epoxide intermediate <bold>31</bold> which was further modified by methyltransferase and two C-glycosyltransferases to yield hedamycin (<xref rid="molecules-27-06387-f007" ref-type="fig">Figure 7</xref>). </p><p>Trioxacarcins (TXNs), firstly isolated from <italic toggle="yes">Streptomyces bottropensis</italic> NRRL 12051 in 1981, exhibit extraordinary antibacterial, antimalarial, and antitumor activities [<xref rid="B45-molecules-27-06387" ref-type="bibr">45</xref>]. Among the TXNs, TXN A (<bold>35</bold>) showed the most potent antitumor activities with sub-nanomolar IC<sub>50</sub> values against various cancer cell lines (<xref rid="molecules-27-06387-f008" ref-type="fig">Figure 8</xref>A). The unique fused spiro-epoxide of TXN A is essential for its bioactivities because the epoxide can react with N-7 of guanine to form a DNA&#x02013;TXN A complex (<xref rid="molecules-27-06387-f008" ref-type="fig">Figure 8</xref>B). The crystal structure of this complex revealed that glycosyl groups at C-4 and C-13 were docked with the minor and major groove, respectively [<xref rid="B46-molecules-27-06387" ref-type="bibr">46</xref>]. It also displayed an unexpected flipping out of the base at the intercalation site, which might be important for DNA&#x02013;protein interaction. Recently, the study of the TXN analog LL-D49194&#x003b1;1 (<bold>36</bold>) showed that the deglycosylated compounds (<bold>37</bold> and <bold>38</bold>) exhibited more potent anticancer activities than <bold>36,</bold> possibly suggesting a new mode of interaction with DNA (<xref rid="molecules-27-06387-f008" ref-type="fig">Figure 8</xref>A) [<xref rid="B47-molecules-27-06387" ref-type="bibr">47</xref>]. Furthermore, the DNA&#x02013;TXN complex (<bold>39</bold>) could be cleaved to yield gutingimycin (<bold>40</bold>) involving a self-resistance mechanism of an excising base (<xref rid="molecules-27-06387-f008" ref-type="fig">Figure 8</xref>B) [<xref rid="B48-molecules-27-06387" ref-type="bibr">48</xref>,<xref rid="B49-molecules-27-06387" ref-type="bibr">49</xref>]. Recently, four DNA glycosylases, TxnU2, TxnU4, LldU1, and LldU5, were reported to be responsible for excising the intercalated guanine adducts [<xref rid="B50-molecules-27-06387" ref-type="bibr">50</xref>].</p><p>Based on the work of Zhang et al., TXNs were also biosynthesized from anthraquinone-intermediate parimycin (<bold>47</bold>), similarly to the precursor of hedamycin, as revealed by gene-deletion experiments [<xref rid="B45-molecules-27-06387" ref-type="bibr">45</xref>]. According to isotope-labelled precursor feeding experiments, the unusual starter unit 2-methylbutyryl of TXNs was derived from L-isoleucine through transamination. After a series of modifications, including condensation with acetyl-CoA and decarboxylation, this starter unit was incorporated into the polyketide chain in virtue of KSIII (<xref rid="molecules-27-06387-f009" ref-type="fig">Figure 9</xref>). The formation and subsequent cyclization of the polyketide chain provided intermediate <bold>46,</bold> whose pyrone ring was formed by a CalC-like protein, TxnO9 [<xref rid="B51-molecules-27-06387" ref-type="bibr">51</xref>]. The decarboxylated intermediate <bold>47</bold> underwent complex tailoring steps to afford intermediate <bold>51</bold> with a unique spiro-epoxide structure, but the specific enzymatic process and mechanism remained uncharacterized. Following that, the methylation of <bold>51</bold> at C-4 and C-13 yielded <bold>52,</bold> whose C4-sugar was finally acetylated by the membrane-bound <italic toggle="yes">O</italic>-acetyltransferase TxnB11 to form <bold>35</bold> (<xref rid="molecules-27-06387-f009" ref-type="fig">Figure 9</xref>) [<xref rid="B52-molecules-27-06387" ref-type="bibr">52</xref>]. Unlike TXNs, the C-16 and C-4 of <bold>45</bold> were glycosylated and methylated to produce LL-D49194&#x003b1;1. </p></sec><sec id="sec3dot2-molecules-27-06387"><title>3.2. Mitomycins</title><p>Mitomycins (MMs, such as MMA, B, and C) are antitumor NPs discovered in <italic toggle="yes">Streptomyces.</italic> They all contain the quinone backbone and a unique azabicycle moiety (<xref rid="molecules-27-06387-f010" ref-type="fig">Figure 10</xref>A) [<xref rid="B18-molecules-27-06387" ref-type="bibr">18</xref>,<xref rid="B53-molecules-27-06387" ref-type="bibr">53</xref>]. Among these compounds, MMC has been used as a chemotherapeutic agent in the clinic for more than five decades. MMC can form inter-strand and intra-strand cross-linking with DNA at the selective sequence (5&#x02019;-CG-3&#x02019;) and resides in the minor groove [<xref rid="B54-molecules-27-06387" ref-type="bibr">54</xref>]. Other compounds of the mitomycin family, such as FR900482 and FR66979, also showed potent DNA cross-linking activity as well as bioactivities against cancer cell lines (<xref rid="molecules-27-06387-f010" ref-type="fig">Figure 10</xref>A). FR900482 was superior to MMC in both efficacy and safety [<xref rid="B55-molecules-27-06387" ref-type="bibr">55</xref>]. </p><p>The mode of action of MMs is well studied. Firstly, a reductive pathway is required to activate the quinone moiety of MMC by either enzymatic or chemical means to form the hydroquinone intermediate <bold>60</bold> [<xref rid="B18-molecules-27-06387" ref-type="bibr">18</xref>,<xref rid="B53-molecules-27-06387" ref-type="bibr">53</xref>]. Subsequent elimination of methanol in <bold>60</bold> affords <bold>61</bold> which undergoes tautomerization and the ring-open reaction of aziridine ring to yield <bold>65</bold> (<xref rid="molecules-27-06387-f010" ref-type="fig">Figure 10</xref>B). The N-2 of guanine attacks the C-1 position to generate the DNA&#x02013;compound complex, then the departure of carbamate produces the iminium intermediate <bold>69,</bold> which is attached by the second guanine of DNA in the same way to form <bold>71</bold>. Furthermore, the first reductive activation could be inhibited by a FAD-dependent oxidoreductase MCRA (encoded by <italic toggle="yes">mcrA</italic>) which enables the oxidization of the hydroquinone form to the quinone form to confer self-resistance [<xref rid="B56-molecules-27-06387" ref-type="bibr">56</xref>,<xref rid="B57-molecules-27-06387" ref-type="bibr">57</xref>,<xref rid="B58-molecules-27-06387" ref-type="bibr">58</xref>,<xref rid="B59-molecules-27-06387" ref-type="bibr">59</xref>]. Although the alkylating mechanism of FR900482 is similar to that of MMC, it is activated by cleaving the N-O bond to form <bold>59</bold> (<xref rid="molecules-27-06387-f010" ref-type="fig">Figure 10</xref>B). </p><p>Since these compounds possess excellent bioactivities and the common pharmacophoric group azabicycle, their synthesis has attracted extensive attention. In chemical synthesis, the azabicycle moiety of MMs is installed from benzazocane intermediates via intramolecular substitution [<xref rid="B60-molecules-27-06387" ref-type="bibr">60</xref>], but their biosynthetic pathways are still not well elucidated. According to isotopic precursors feeding experiments conducted by Hornemann et al., the origins of the <italic toggle="yes">O</italic>-methyl group and the carbamate were methionine and L-citrulline, respectively, while the mitosane core was derived from 3-amino-5-hydroxybenzoic acid (AHBA, <bold>81</bold>) and glucosamine [<xref rid="B61-molecules-27-06387" ref-type="bibr">61</xref>,<xref rid="B62-molecules-27-06387" ref-type="bibr">62</xref>]. The precursor AHBA was formed via the amino-shikimate pathway related to rifamycin and kanosamine biosynthesis [<xref rid="B63-molecules-27-06387" ref-type="bibr">63</xref>,<xref rid="B64-molecules-27-06387" ref-type="bibr">64</xref>]. After the formation of AHBA, it was firstly activated by acyl AMP-ligase MitE and was then loaded onto acyl carrier protein (ACP) MmcB (<xref rid="molecules-27-06387-f011" ref-type="fig">Figure 11</xref>). The glycosyltransferase MitB was verified to catalyze the glycosylation of AHBA-MmcB with UDP-GlcNAc [<xref rid="B65-molecules-27-06387" ref-type="bibr">65</xref>,<xref rid="B66-molecules-27-06387" ref-type="bibr">66</xref>,<xref rid="B67-molecules-27-06387" ref-type="bibr">67</xref>]. Recently, Wang et al. traced all the ACP-channelled MM intermediates indicating that AHBA-MmcB-GlcNAc intermediate <bold>85</bold> should undergo the deacetylation by MitC to form <bold>86</bold> which was further transformed to <bold>88</bold> by MitF and MitD [<xref rid="B68-molecules-27-06387" ref-type="bibr">68</xref>]. The epoxide intermediate might be cyclized to provide benzazocine <bold>92</bold>. <bold>92</bold> then underwent oxidation and several uncovered modifications to generate hydroxyquinone intermediate <bold>95</bold> which was methylated to afford MMA, the direct precursor of MMC [<xref rid="B69-molecules-27-06387" ref-type="bibr">69</xref>]. Sherman and co-workers also identified a methyltransferase MitM which methylated the nitrogen of aziridine in MMA rather than MMC to yield MMF (<bold>96</bold>) [<xref rid="B70-molecules-27-06387" ref-type="bibr">70</xref>]. In addition, the epoxide of <bold>88</bold> could be opened by the nucleophilic attack to afford <bold>89</bold> which was the precursor of the MMs with &#x003b1;-C9. Moreover, the oxidation of the aniline amine in <bold>89</bold> facilitated forming the core structure of FR900482. </p></sec><sec id="sec3dot3-molecules-27-06387"><title>3.3. Azinomycins</title><p>The antitumor antibiotics azinomycin A (<bold>98</bold>) and B (<bold>99</bold>) contain naphthoic acid (NPA) moiety, epoxide, and azabicyclohexane ring which all contribute to alkylating DNA (<xref rid="molecules-27-06387-f012" ref-type="fig">Figure 12</xref>) [<xref rid="B71-molecules-27-06387" ref-type="bibr">71</xref>]. The electrophilic epoxide and aziridine can both be attacked by N-7 of guanine and the latter can even be opened by N-7 of adenine, leading to the formation of interstrand DNA cross-links (<xref rid="molecules-27-06387-f012" ref-type="fig">Figure 12</xref>) [<xref rid="B72-molecules-27-06387" ref-type="bibr">72</xref>,<xref rid="B73-molecules-27-06387" ref-type="bibr">73</xref>]. NPA moiety also plays an important role in the DNA alkylating activity by virtue of non-covalent interactions [<xref rid="B74-molecules-27-06387" ref-type="bibr">74</xref>]. In 2011, the aminoglycoside transferase AziR was identified to mediate the self-resistance of azinomycin and reduce the DNA damage via binding azinomycin. Recently, a novel DNA glycosylase Orf1 and an endonuclease AziN were reported to repair the DNA damage to achieve self-protection [<xref rid="B75-molecules-27-06387" ref-type="bibr">75</xref>,<xref rid="B76-molecules-27-06387" ref-type="bibr">76</xref>,<xref rid="B77-molecules-27-06387" ref-type="bibr">77</xref>,<xref rid="B78-molecules-27-06387" ref-type="bibr">78</xref>].</p><p>Previous isotope-labelled precursor feeding experiments revealed that the epoxy moiety, the azabicyclic fragment, and the terminal part in azinomycin B were derived from acetyl-CoA, valine, glutamic, and threonine, respectively (<xref rid="molecules-27-06387-f013" ref-type="fig">Figure 13</xref>) [<xref rid="B79-molecules-27-06387" ref-type="bibr">79</xref>,<xref rid="B80-molecules-27-06387" ref-type="bibr">80</xref>]. The feeding experiments with isotopically labelled substrates showed that 3-methyl-2-oxobutenoate (<bold>105</bold>) was incorporated into the azinomycin epoxide as the penultimate precursor (<xref rid="molecules-27-06387-f014" ref-type="fig">Figure 14</xref>A). The formation of <bold>105</bold> was achieved by oxidation, transamination as well as dehydration beginning with L-valine. Even so, the exact timing of forming epoxy amide remains unclear up to now [<xref rid="B81-molecules-27-06387" ref-type="bibr">81</xref>].</p><p>In the biosynthesis of this class of non-ribosomal peptide-polyketide hybrid compounds, iterative type I PKS AziB catalysed the formation of 5-methyl-NPA (<bold>100</bold>) which was further transformed to 3-methoxy-5-methyl-NPA (<bold>102</bold>) by a P450 hydroxylase AziB1 and the <italic toggle="yes">O</italic>-methyltransferase AziB2 (<xref rid="molecules-27-06387-f014" ref-type="fig">Figure 14</xref>B) [<xref rid="B82-molecules-27-06387" ref-type="bibr">82</xref>]. The first building block <bold>102</bold> was activated by the distinct adenylation (A) domain of the di-domain non-ribosomal peptide synthetase (NRPS) AziA1 to initiate the backbone formation of azinomycins [<xref rid="B83-molecules-27-06387" ref-type="bibr">83</xref>,<xref rid="B84-molecules-27-06387" ref-type="bibr">84</xref>].</p><p>The azabicycle moiety was constructed from 3,4-epoxypiperidine derivatives via spontaneously intramolecular substitution in chemical synthesis [<xref rid="B85-molecules-27-06387" ref-type="bibr">85</xref>]. Watanabe and co-workers unraveled the biosynthetic pathway of the azabicyclic fragment in azinomycin, wherein the glutamic acid was initially acetylated at the amino group by <italic toggle="yes">N</italic>-acetyltransferase AziC2 to form <italic toggle="yes">N</italic>-acetyl glutamate <bold>106</bold>. The <italic toggle="yes">N</italic>-acetyl glutamate kinase AziC3 subsequently phosphorylated the carboxyl to afford the <italic toggle="yes">N</italic>-acetyl-glutamyl 5-phosphate (<bold>107</bold>) which was subsequently reduced to <italic toggle="yes">N</italic>-acetyl-glutamate-5-semialdehyde (<bold>108</bold>) by an <italic toggle="yes">N</italic>-acetyl-&#x003b3;-glutamate phosphate reductase AziC4 (<xref rid="molecules-27-06387-f014" ref-type="fig">Figure 14</xref>C), and the key two-carbon extension on aldehyde intermediate catalyzed by the transketolase AziC5/C6 afforded <bold>110</bold> which was further converted to the acetylated nonproteinogenic amino acid diamino-dihydroxy-heptanoic acid (DADH, <bold>111</bold>) by an aminotransferase (AziC1 or AziC7) [<xref rid="B86-molecules-27-06387" ref-type="bibr">86</xref>,<xref rid="B87-molecules-27-06387" ref-type="bibr">87</xref>,<xref rid="B88-molecules-27-06387" ref-type="bibr">88</xref>]. Recently, Kurosawa et al. demonstrated that <bold>111</bold> could be further sulphated to <bold>112</bold> and the sulfate group in <bold>112</bold> was finally attacked by the ortho amino group to form the aziridine ring intermediate <bold>113</bold> which may be subsequently acetylated and cyclized to form the azabicyclic fragment <bold>114</bold> (<xref rid="molecules-27-06387-f014" ref-type="fig">Figure 14</xref>C) [<xref rid="B89-molecules-27-06387" ref-type="bibr">89</xref>]. Additionally, glutamic acid might be firstly activated by the amino-group carrier protein (AmCP) and was further modified to produce DADH which was then introduced into the azabicyclic structure according to a recent study about the biosynthesis of vazabitide A [<xref rid="B90-molecules-27-06387" ref-type="bibr">90</xref>]. Moreover, the enol in the final building block of azinomycin B was generated by the oxidation of L-threonine, while the decarboxylation of the intermediate <bold>116</bold> afforded the aminoacetone <bold>117</bold> in azinomycin A [<xref rid="B91-molecules-27-06387" ref-type="bibr">91</xref>].</p></sec></sec><sec id="sec4-molecules-27-06387"><title>4. DNA-Alkylating Natural Products with Imine as Warheads</title><sec id="sec4dot1-molecules-27-06387"><title>4.1. Pyrrolobenzodiazepines</title><p>Antitumor antibiotics pyrrolobenzodiazepines (PDBs), including anthramycin, sibiromycin, and tomaymycin, all contain three parts: anthranilate, diazepine, and hydropyrrole (<xref rid="molecules-27-06387-f015" ref-type="fig">Figure 15</xref>A) [<xref rid="B92-molecules-27-06387" ref-type="bibr">92</xref>,<xref rid="B93-molecules-27-06387" ref-type="bibr">93</xref>]. The imine in the diazepine can be attacked by N-2 of guanine to form a stable covalent bond resulting in inhibiting DNA synthesis (<xref rid="molecules-27-06387-f015" ref-type="fig">Figure 15</xref>C) [<xref rid="B94-molecules-27-06387" ref-type="bibr">94</xref>]. Moreover, the crystal structure of the anthramycin-DNA complex indicates that the <italic toggle="yes">S</italic>-configuration of C-11a make it suitable for docking in the minor groove of DNA [<xref rid="B95-molecules-27-06387" ref-type="bibr">95</xref>,<xref rid="B96-molecules-27-06387" ref-type="bibr">96</xref>]. In addition, a PDB dimer, SJG-136 (<bold>121</bold>), which has completed the phase II clinical trial for treating leukemia and ovarian cancer, can form DNA inter-strand and intra-strand cross-linking of DNA (<xref rid="molecules-27-06387-f015" ref-type="fig">Figure 15</xref>B) [<xref rid="B97-molecules-27-06387" ref-type="bibr">97</xref>,<xref rid="B98-molecules-27-06387" ref-type="bibr">98</xref>].</p><p>Based on previous feeding experiments, L-methionine, L-tyrosine, and L-tryptophan were supposed to be the biosynthetic precursors of pyrrolobenzodiazepines (<xref rid="molecules-27-06387-f015" ref-type="fig">Figure 15</xref>A) [<xref rid="B99-molecules-27-06387" ref-type="bibr">99</xref>]. Like lincomycin biosynthesis, L-dopa from L-tyrosine is cleaved to yield semialdehyde intermediate <bold>123</bold>, followed by intramolecular cyclization to form dihydropyrrole intermediate <bold>124</bold> (<xref rid="molecules-27-06387-f016" ref-type="fig">Figure 16</xref>A) [<xref rid="B100-molecules-27-06387" ref-type="bibr">100</xref>]. The decarboxylation of intermediate <bold>124</bold> generates <bold>125,</bold> which is further converted into a variety of dihydropyrrole precursors (<bold>130</bold>-<bold>132</bold>) to be introduced into PDB biosynthesis [<xref rid="B101-molecules-27-06387" ref-type="bibr">101</xref>,<xref rid="B102-molecules-27-06387" ref-type="bibr">102</xref>,<xref rid="B103-molecules-27-06387" ref-type="bibr">103</xref>]. For the biosynthesis of hydroxyanthranilic acid intermediates, L-tryptophan was firstly degraded to L-kynurenine (<bold>134</bold>), the biosynthetic precursor of important NPs including actinomycin, quinolobactin, and daptomycin [<xref rid="B104-molecules-27-06387" ref-type="bibr">104</xref>,<xref rid="B105-molecules-27-06387" ref-type="bibr">105</xref>,<xref rid="B106-molecules-27-06387" ref-type="bibr">106</xref>]. Following this, <bold>134</bold> goes through three continuous tailoring steps mediated by monooxygenase, kynurenine hydrolase, and methyltransferase, respectively, to generate 3-hydroxyl-4-methyl-anthranilic acid (<bold>137</bold>), which is subsequently introduced into the anthramycin or oxidized to be the precursor (<bold>138</bold>) of sibiromycin (<xref rid="molecules-27-06387-f016" ref-type="fig">Figure 16</xref>B) [<xref rid="B107-molecules-27-06387" ref-type="bibr">107</xref>]. Two NRPSs containing two (A-PCP) and four domains (C-A-PCP-RE), respectively, are responsible for the formation of the amide bond between two building blocks, and the release and intermolecular cyclization of the chain to afford <bold>139</bold>, which is dehydrated to form the final compounds with imine moieties (<xref rid="molecules-27-06387-f016" ref-type="fig">Figure 16</xref>C) [<xref rid="B108-molecules-27-06387" ref-type="bibr">108</xref>]. </p></sec><sec id="sec4dot2-molecules-27-06387"><title>4.2. Tetrahydroisoquinolines</title><p>Tetrahydroisoquinoline NPs are mainly classified into three subfamilies composed of the saframycin (SFM) family including SFM A (<bold>141</bold>) and ET-743 (<bold>143</bold>) and the naphthyridinomycin (NDM) family, including NDM A (<bold>140</bold>), as well as the quinocarcin family compounds (<xref rid="molecules-27-06387-f017" ref-type="fig">Figure 17</xref>A) [<xref rid="B109-molecules-27-06387" ref-type="bibr">109</xref>]. Most SFMs exhibit inhibitory activity against cancer cell lines by alkylating DNA. ET-743, produced by the bacterial symbiont <italic toggle="yes">Candidatus Endoecteinascidia frumentensis</italic>, displayed the most potent antitumor activities and has been used clinically to treat ovarian neoplasms and sarcomas [<xref rid="B110-molecules-27-06387" ref-type="bibr">110</xref>]. Two mechanisms of SFM A for alkylating DNA were reported. One way was the formation of iminium intermediate <bold>148</bold> through reduction of the quinone moiety (<xref rid="molecules-27-06387-f017" ref-type="fig">Figure 17</xref>B) [<xref rid="B111-molecules-27-06387" ref-type="bibr">111</xref>]. In the other way, the ortho-position nitrogen could directly promote the departure of the functional group in C-21 to yield the iminium intermediate <bold>144</bold>. Both <bold>144</bold> and <bold>148</bold> could be attacked by nucleophilic N-2 residue of guanine in GC-rich regions of DNA to form the DNA&#x02013;drug complex (<xref rid="molecules-27-06387-f017" ref-type="fig">Figure 17</xref>B) [<xref rid="B112-molecules-27-06387" ref-type="bibr">112</xref>]. Furthermore, a FAD-binding oxidoreductase NapU encoded in BGC of NDM was reported to activate and inactivate the matured prodrug by extracellular oxidation conferring self-protection [<xref rid="B113-molecules-27-06387" ref-type="bibr">113</xref>]. Recently, a short-chain dehydrogenase NapW mediated the reduction of the hemiaminal pharmacophore, implicating another level of the self-resistance mechanism of the tetrahydroisoquinoline family [<xref rid="B114-molecules-27-06387" ref-type="bibr">114</xref>].</p><p>Isotope-labeled precursor feeding experiments have revealed that the skeleton structure of SFMs is derived from tyrosine, alanine, glycine, and methionine (<xref rid="molecules-27-06387-f018" ref-type="fig">Figure 18</xref>) [<xref rid="B115-molecules-27-06387" ref-type="bibr">115</xref>,<xref rid="B116-molecules-27-06387" ref-type="bibr">116</xref>]. L-tyrosine undergoes <italic toggle="yes">C</italic>-methylation, oxidation, and <italic toggle="yes">O</italic>-methylation to afford the precursor 3-hydroxy-5-methyl-<italic toggle="yes">O</italic>-methyltyrosine (<bold>152</bold>) (<xref rid="molecules-27-06387-f019" ref-type="fig">Figure 19</xref>A) [<xref rid="B117-molecules-27-06387" ref-type="bibr">117</xref>,<xref rid="B118-molecules-27-06387" ref-type="bibr">118</xref>]. In 2010, Oikawa and co-workers reconstituted the formation of the core structure in vitro, revealing that two Pictet&#x02013;Spengler (PS) reactions were involved in this process. Specifically, <bold>152</bold> was firstly activated and uploaded onto PCP of NRPS SfmC, assembling with intermediate <bold>153</bold> produced by NRPSs SfmA and SfmB via the first PS reaction. Following this, <bold>154</bold> formed by the subsequent reduction underwent a second PS reaction and reduction to generate <bold>155</bold> (<xref rid="molecules-27-06387-f019" ref-type="fig">Figure 19</xref>B) [<xref rid="B119-molecules-27-06387" ref-type="bibr">119</xref>,<xref rid="B120-molecules-27-06387" ref-type="bibr">120</xref>]. The following reduction and intramolecular cyclization of <bold>155</bold> yielded <bold>156</bold> which was then oxidized and methylated to generate <bold>157</bold>. Subsequently, <bold>157</bold> was transported outside the cell in company with its fatty acid chain and was removed by the membrane-anchored protein SfmE to produce <bold>158</bold>. Finally, SfmCy2 catalyzed the extracellular deamination of <bold>158</bold> to form <bold>142,</bold> indicating a prodrug maturation process (<xref rid="molecules-27-06387-f020" ref-type="fig">Figure 20</xref>) [<xref rid="B121-molecules-27-06387" ref-type="bibr">121</xref>].</p></sec></sec><sec id="sec5-molecules-27-06387"><title>5. Others</title><sec id="sec5dot1-molecules-27-06387"><title>5.1. Leinamycin</title><p>Antitumor agent leinamycin (LNM, <bold>159</bold>) is a hybrid peptide-polyketide NP and contains a unique 1,3-dioxo-1,2-dithiolane moiety, which is essential for its anticancer activity (<xref rid="molecules-27-06387-f021" ref-type="fig">Figure 21</xref>). The alkylation of DNA involves a rearrangement reaction in which LNM is initially activated via the attack of thiol to form the sulfenic acid intermediate <bold>165</bold>, which also enabled, triggering oxidative DNA cleavage via generating unstable hydrodisulfide intermediate (RSSH) (<xref rid="molecules-27-06387-f021" ref-type="fig">Figure 21</xref>) [<xref rid="B122-molecules-27-06387" ref-type="bibr">122</xref>,<xref rid="B123-molecules-27-06387" ref-type="bibr">123</xref>,<xref rid="B124-molecules-27-06387" ref-type="bibr">124</xref>,<xref rid="B125-molecules-27-06387" ref-type="bibr">125</xref>]. The oxathiolane intermediate <bold>165</bold> could be produced by breaking the S-S bond of LNM via thiol attack or hydrolysis. The C6-C7 alkene of <bold>165</bold> then attacks the electrophilic sulfur of the oxathiolanone group to generate an episulfonium ion intermediate, <bold>166</bold>, following an intermolecular nucleophilic attack with the N7 of guanine residues in duplex DNA to yield the DNA&#x02013;drug adduct <bold>168</bold>. Unlike the reduction-mediated alkylation of DNA by LNM, LNM E1(<bold>160</bold>) could be transformed to its episulfonium ion intermediate <bold>167</bold> through an oxidative reaction catalyzed by reactive oxygen species (<xref rid="molecules-27-06387-f021" ref-type="fig">Figure 21</xref>) [<xref rid="B126-molecules-27-06387" ref-type="bibr">126</xref>].</p><p>The skeleton of LNM was biosynthesized by hybrid NRPS-PKS assembly lines [<xref rid="B127-molecules-27-06387" ref-type="bibr">127</xref>]. The LnmQ, LnmP, and NRPS module of LnmI are responsible for the unique thiazole-containing starter unit. The polyketide chain of LNM is elongated by two AT-less type I PKSs, LnmI and LnmJ, as well as a <italic toggle="yes">trans</italic>-AT enzyme LnmG [<xref rid="B128-molecules-27-06387" ref-type="bibr">128</xref>,<xref rid="B129-molecules-27-06387" ref-type="bibr">129</xref>,<xref rid="B130-molecules-27-06387" ref-type="bibr">130</xref>,<xref rid="B131-molecules-27-06387" ref-type="bibr">131</xref>,<xref rid="B132-molecules-27-06387" ref-type="bibr">132</xref>]. A <italic toggle="yes">&#x003b2;</italic>-branched C3 unit derived from methylmalonyl-CoA was then installed by a set of proteins including a free-standing ACP (LnmL), a bifunctional AT-decarboxylase (LnmK), an HMGS homolog (LnmM), and an ECH homolog (LnmF) (<xref rid="molecules-27-06387-f022" ref-type="fig">Figure 22</xref>) [<xref rid="B133-molecules-27-06387" ref-type="bibr">133</xref>,<xref rid="B134-molecules-27-06387" ref-type="bibr">134</xref>]. Module 8 in LnmJ, containing a domain of unknown function domain (DUF), added an L-cysteine into C-3 of intermediate <bold>170</bold> to produce intermediate <bold>171</bold>. The PLP-dependent cysteine lyase domain (SH) can catalyze the cleavage of the C-S bond to yield <bold>172,</bold> which is cyclized to release the chain to generate LNM E1 (<xref rid="molecules-27-06387-f022" ref-type="fig">Figure 22</xref>) [<xref rid="B135-molecules-27-06387" ref-type="bibr">135</xref>]. Recently, Meng et al. demonstrated that LnmJ-SH domain directly installed a -SSH group into the LNM polyketide scaffold via cleavage of the C-S bond linking the thiocysteine to form LNM E (<bold>173</bold>), which might be further transferred to LNM by a set of uncharacterized enzymes [<xref rid="B136-molecules-27-06387" ref-type="bibr">136</xref>,<xref rid="B137-molecules-27-06387" ref-type="bibr">137</xref>].</p></sec><sec id="sec5dot2-molecules-27-06387"><title>5.2. Gilvocarcins</title><p>Antitumor antibiotic gilvocarcins are a subfamily of <italic toggle="yes">C</italic>-glycoside aromatic polyketides and are derived from the typical angucycline scaffold [<xref rid="B138-molecules-27-06387" ref-type="bibr">138</xref>]. Part of gilvocarcin-type natural products including gilvocarcin V (<bold>174</bold>), chrysomycin A (<bold>175</bold>), and ravidomycin (<bold>176</bold>) (<xref rid="molecules-27-06387-f023" ref-type="fig">Figure 23</xref>A) possess the vinyl substituent at C-8 which mediates a photo-activated [2 + 2] photocycloaddition with the thymidyl residue on DNA (<xref rid="molecules-27-06387-f023" ref-type="fig">Figure 23</xref>B) [<xref rid="B139-molecules-27-06387" ref-type="bibr">139</xref>,<xref rid="B140-molecules-27-06387" ref-type="bibr">140</xref>].</p><p>During the biosynthesis of <bold>174</bold>, the type II PKS and cyclases afford the angucycline precursor <bold>177</bold> starting from the starter unit propionyl-CoA [<xref rid="B141-molecules-27-06387" ref-type="bibr">141</xref>,<xref rid="B142-molecules-27-06387" ref-type="bibr">142</xref>]. Subsequent dehydration of <bold>177</bold> generates <bold>178,</bold> whose C-ring is oxidatively rearranged to yield <bold>182</bold> through possible intermediates <bold>180</bold> and <bold>181</bold>. Following this, <bold>182</bold> is glycosylated to form pregilvocarcin V, which is finally oxidized to gilvocarcin V (<xref rid="molecules-27-06387-f024" ref-type="fig">Figure 24</xref>) [<xref rid="B143-molecules-27-06387" ref-type="bibr">143</xref>,<xref rid="B144-molecules-27-06387" ref-type="bibr">144</xref>,<xref rid="B145-molecules-27-06387" ref-type="bibr">145</xref>,<xref rid="B146-molecules-27-06387" ref-type="bibr">146</xref>].</p></sec></sec><sec id="sec6-molecules-27-06387"><title>6. Perspective</title><p>Since DNA-alkylating NPs exhibit potent antitumor activity, their biosynthesis has received extensive attention. Obviously, the highly active functional groups including epoxide, cyclopropane, aziridine, and imine in their chemical structures play an important role in alkylating DNA to form the DNA&#x02013;drug adduct. Elucidation of their biosynthetic pathways not only facilitates the discovery of new NPs with these biological active groups by genome mining but also is valuable for engineering NPs and drug design [<xref rid="B147-molecules-27-06387" ref-type="bibr">147</xref>]. The unprecedented enzymology involved in their biosynthetic pathways can exert a positive influence on the development of biocatalysts as well. As a result of their strong DNA-alkylating activities, their producers have to confer self-resistance strategies to avoid damaging themselves, mainly through the cleavage of the DNA&#x02013;drug complex or modification of the functional groups. Therefore, resistant gene-guided genome mining also contributes to discovering new DNA-alkylating antibiotics [<xref rid="B148-molecules-27-06387" ref-type="bibr">148</xref>]. In addition, other moieties which contribute to affinity and reactivity with DNA are also indispensable for their ability to alkylate DNA. The modification of these moieties may enhance their activity or sensitivity and facilitate linking the NPs to antibodies via chemical synthesis.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, Q.-Y.N., Y.H. and G.-L.T.; writing&#x02014;original draft preparation, Q.-Y.N. and Y.H.; writing&#x02014;review and editing, Q.-Y.N., Y.H., X.-F.H. and G.-L.T.; supervision, G.-L.T.; All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-27-06387"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newman</surname><given-names>D.J.</given-names></name>
<name><surname>Cragg</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>770</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><?supplied-pmid 32162523?><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref><ref id="B2-molecules-27-06387"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rajski</surname><given-names>S.R.</given-names></name>
<name><surname>Williams</surname><given-names>R.M.</given-names></name>
</person-group><article-title>DNA Cross-Linking Agents as Antitumor Drugs</article-title><source>Chem. Rev.</source><year>1998</year><volume>98</volume><fpage>2723</fpage><lpage>2796</lpage><pub-id pub-id-type="doi">10.1021/cr9800199</pub-id><?supplied-pmid 11848977?><pub-id pub-id-type="pmid">11848977</pub-id></element-citation></ref><ref id="B3-molecules-27-06387"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Klaunig</surname><given-names>J.E.</given-names></name>
<name><surname>Kamendulis</surname><given-names>L.M.</given-names></name>
</person-group><article-title>Carcinogenicity</article-title><source>Comprehensive Toxicology</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2010</year><fpage>117</fpage><lpage>138</lpage><isbn>978-0-08-046884-6</isbn></element-citation></ref><ref id="B4-molecules-27-06387"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nougayr&#x000e8;de</surname><given-names>J.-P.</given-names></name>
<name><surname>Homburg</surname><given-names>S.</given-names></name>
<name><surname>Taieb</surname><given-names>F.</given-names></name>
<name><surname>Boury</surname><given-names>M.</given-names></name>
<name><surname>Brzuszkiewicz</surname><given-names>E.</given-names></name>
<name><surname>Gottschalk</surname><given-names>G.</given-names></name>
<name><surname>Buchrieser</surname><given-names>C.</given-names></name>
<name><surname>Hacker</surname><given-names>J.</given-names></name>
<name><surname>Dobrindt</surname><given-names>U.</given-names></name>
<name><surname>Oswald</surname><given-names>E.</given-names></name>
</person-group><article-title><italic toggle="yes">Escherichia Coli</italic> Induces DNA Double-Strand Breaks in Eukaryotic Cells</article-title><source>Science</source><year>2006</year><volume>313</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1126/science.1127059</pub-id><?supplied-pmid 16902142?><pub-id pub-id-type="pmid">16902142</pub-id></element-citation></ref><ref id="B5-molecules-27-06387"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xue</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>C.S.</given-names></name>
<name><surname>Healy</surname><given-names>A.R.</given-names></name>
<name><surname>Wernke</surname><given-names>K.M.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Frischling</surname><given-names>M.C.</given-names></name>
<name><surname>Shine</surname><given-names>E.E.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Herzon</surname><given-names>S.B.</given-names></name>
<name><surname>Crawford</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Structure Elucidation of Colibactin and Its DNA Cross-Links</article-title><source>Science</source><year>2019</year><volume>365</volume><fpage>eaax2685</fpage><pub-id pub-id-type="doi">10.1126/science.aax2685</pub-id><pub-id pub-id-type="pmid">31395743</pub-id></element-citation></ref><ref id="B6-molecules-27-06387"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>M.R.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.</given-names></name>
<name><surname>Villalta</surname><given-names>P.W.</given-names></name>
<name><surname>Stornetta</surname><given-names>A.</given-names></name>
<name><surname>Boudreau</surname><given-names>P.D.</given-names></name>
<name><surname>Carr&#x000e1;</surname><given-names>A.</given-names></name>
<name><surname>Brennan</surname><given-names>C.A.</given-names></name>
<name><surname>Chun</surname><given-names>E.</given-names></name>
<name><surname>Ngo</surname><given-names>L.</given-names></name>
<name><surname>Samson</surname><given-names>L.D.</given-names></name>
<etal/>
</person-group><article-title>The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA</article-title><source>Science</source><year>2019</year><volume>363</volume><fpage>eaar7785</fpage><pub-id pub-id-type="doi">10.1126/science.aar7785</pub-id><pub-id pub-id-type="pmid">30765538</pub-id></element-citation></ref><ref id="B7-molecules-27-06387"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wolkenberg</surname><given-names>S.E.</given-names></name>
<name><surname>Boger</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Mechanisms of in Situ Activation for DNA-Targeting Antitumor Agents</article-title><source>Chem. Rev.</source><year>2002</year><volume>102</volume><fpage>2477</fpage><lpage>2496</lpage><pub-id pub-id-type="doi">10.1021/cr010046q</pub-id><pub-id pub-id-type="pmid">12105933</pub-id></element-citation></ref><ref id="B8-molecules-27-06387"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barr</surname><given-names>J.R.</given-names></name>
<name><surname>Van Atta</surname><given-names>R.B.</given-names></name>
<name><surname>Natrajan</surname><given-names>A.</given-names></name>
<name><surname>Hecht</surname><given-names>S.M.</given-names></name>
<name><surname>Van der Marel</surname><given-names>G.A.</given-names></name>
<name><surname>Van Boom</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Iron(II) Bleomycin-Mediated Reduction of Oxygen to Water: An Oxygen-17 NMR Study</article-title><source>J. Am. Chem. Soc.</source><year>1990</year><volume>112</volume><fpage>4058</fpage><lpage>4060</lpage><pub-id pub-id-type="doi">10.1021/ja00166a064</pub-id></element-citation></ref><ref id="B9-molecules-27-06387"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Konishi</surname><given-names>M.</given-names></name>
<name><surname>Ohkuma</surname><given-names>H.</given-names></name>
<name><surname>Tsuno</surname><given-names>T.</given-names></name>
<name><surname>Oki</surname><given-names>T.</given-names></name>
<name><surname>VanDuyne</surname><given-names>G.D.</given-names></name>
<name><surname>Clardy</surname><given-names>J.</given-names></name>
</person-group><article-title>Crystal and Molecular Structure of Dynemicin A: A Novel 1,5-Diyn-3-Ene Antitumor Antibiotic</article-title><source>J. Am. Chem. Soc.</source><year>1990</year><volume>112</volume><fpage>3715</fpage><lpage>3716</lpage><pub-id pub-id-type="doi">10.1021/ja00165a097</pub-id></element-citation></ref><ref id="B10-molecules-27-06387"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Snyder</surname><given-names>J.P.</given-names></name>
<name><surname>Tipsword</surname><given-names>G.E.</given-names></name>
</person-group><article-title>Proposal for Blending Classical and Biradical Mechanisms in Antitumor Antibiotics: Dynemicin A</article-title><source>J. Am. Chem. Soc.</source><year>1990</year><volume>112</volume><fpage>4040</fpage><lpage>4042</lpage><pub-id pub-id-type="doi">10.1021/ja00166a052</pub-id></element-citation></ref><ref id="B11-molecules-27-06387"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellestad</surname><given-names>G.A.</given-names></name>
<name><surname>Hamann</surname><given-names>P.R.</given-names></name>
<name><surname>Zein</surname><given-names>N.</given-names></name>
<name><surname>Morton</surname><given-names>G.O.</given-names></name>
<name><surname>Siegel</surname><given-names>M.M.</given-names></name>
<name><surname>Pastel</surname><given-names>M.</given-names></name>
<name><surname>Borders</surname><given-names>D.B.</given-names></name>
<name><surname>McGahren</surname><given-names>W.J.</given-names></name>
</person-group><article-title>Reactions of the Trisulfide Moiety in Calicheamicin</article-title><source>Tetrahedron Lett.</source><year>1989</year><volume>30</volume><fpage>3033</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)99395-X</pub-id></element-citation></ref><ref id="B12-molecules-27-06387"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Myers</surname><given-names>A.G.</given-names></name>
<name><surname>Cohen</surname><given-names>S.B.</given-names></name>
<name><surname>Kwon</surname><given-names>B.M.</given-names></name>
</person-group><article-title>A Study of the Reaction of Calicheamicin.Gamma.1 with Glutathione in the Presence of Double-Stranded DNA</article-title><source>J. Am. Chem. Soc.</source><year>1994</year><volume>116</volume><fpage>1255</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1021/ja00083a012</pub-id></element-citation></ref><ref id="B13-molecules-27-06387"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ng</surname><given-names>T.L.</given-names></name>
<name><surname>Rohac</surname><given-names>R.</given-names></name>
<name><surname>Mitchell</surname><given-names>A.J.</given-names></name>
<name><surname>Boal</surname><given-names>A.K.</given-names></name>
<name><surname>Balskus</surname><given-names>E.P.</given-names></name>
</person-group><article-title>An N-Nitrosating Metalloenzyme Constructs the Pharmacophore of Streptozotocin</article-title><source>Nature</source><year>2019</year><volume>566</volume><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0894-z</pub-id><pub-id pub-id-type="pmid">30728519</pub-id></element-citation></ref><ref id="B14-molecules-27-06387"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>M.J.</given-names></name>
<name><surname>Sil</surname><given-names>D.</given-names></name>
<name><surname>Ng</surname><given-names>T.L.</given-names></name>
<name><surname>Crooke</surname><given-names>A.M.</given-names></name>
<name><surname>Kenney</surname><given-names>G.E.</given-names></name>
<name><surname>Tysoe</surname><given-names>C.R.</given-names></name>
<name><surname>Zhang</surname><given-names>B.</given-names></name>
<name><surname>Balskus</surname><given-names>E.P.</given-names></name>
<name><surname>Boal</surname><given-names>A.K.</given-names></name>
<name><surname>Krebs</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>A Peroxodiiron(III/III) Intermediate Mediating Both <italic toggle="yes">N</italic> -Hydroxylation Steps in Biosynthesis of the <italic toggle="yes">N</italic> -Nitrosourea Pharmacophore of Streptozotocin by the Multi-Domain Metalloenzyme SznF</article-title><source>J. Am. Chem. Soc.</source><year>2020</year><volume>142</volume><fpage>11818</fpage><lpage>11828</lpage><pub-id pub-id-type="doi">10.1021/jacs.0c03431</pub-id><pub-id pub-id-type="pmid">32511919</pub-id></element-citation></ref><ref id="B15-molecules-27-06387"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Veglia</surname><given-names>F.</given-names></name>
<name><surname>Matullo</surname><given-names>G.</given-names></name>
<name><surname>Vineis</surname><given-names>P.</given-names></name>
</person-group><article-title>Bulky DNA Adducts and Risk of Cancer: A Meta-Analysis</article-title><source>Cancer Epidemiol. Biomark. Prev.</source><year>2003</year><volume>12</volume><fpage>157</fpage><lpage>160</lpage></element-citation></ref><ref id="B16-molecules-27-06387"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Motwani</surname><given-names>H.V.</given-names></name>
</person-group><article-title>DNA as an in Vitro Trapping Agent for Detection of Bulky Genotoxic Metabolites</article-title><source>J. Chromatogr. B</source><year>2020</year><volume>1152</volume><fpage>122276</fpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2020.122276</pub-id></element-citation></ref><ref id="B17-molecules-27-06387"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Neill</surname><given-names>E.C.</given-names></name>
<name><surname>Schorn</surname><given-names>M.</given-names></name>
<name><surname>Larson</surname><given-names>C.B.</given-names></name>
<name><surname>Mill&#x000e1;n-Agui&#x000f1;aga</surname><given-names>N.</given-names></name>
</person-group><article-title>Targeted Antibiotic Discovery through Biosynthesis-Associated Resistance Determinants: Target Directed Genome Mining</article-title><source>Crit. Rev. Microbiol.</source><year>2019</year><volume>45</volume><fpage>255</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2019.1590307</pub-id><pub-id pub-id-type="pmid">30985219</pub-id></element-citation></ref><ref id="B18-molecules-27-06387"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Galm</surname><given-names>U.</given-names></name>
<name><surname>Hager</surname><given-names>M.H.</given-names></name>
<name><surname>Van Lanen</surname><given-names>S.G.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin</article-title><source>Chem. Rev.</source><year>2005</year><volume>105</volume><fpage>739</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1021/cr030117g</pub-id><pub-id pub-id-type="pmid">15700963</pub-id></element-citation></ref><ref id="B19-molecules-27-06387"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Igarashi</surname><given-names>Y.</given-names></name>
<name><surname>Futamata</surname><given-names>K.</given-names></name>
<name><surname>Fujita</surname><given-names>T.</given-names></name>
<name><surname>Sekine</surname><given-names>A.</given-names></name>
<name><surname>Senda</surname><given-names>H.</given-names></name>
<name><surname>Naoki</surname><given-names>H.</given-names></name>
<name><surname>Furumai</surname><given-names>T.</given-names></name>
</person-group><article-title>Yatakemycin, a Novel Antifungal Antibiotic Produced by <italic toggle="yes">Streptomyces</italic> Sp. TP-A0356</article-title><source>J. Antibiot.</source><year>2003</year><volume>56</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.56.107</pub-id></element-citation></ref><ref id="B20-molecules-27-06387"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hanka</surname><given-names>L.J.</given-names></name>
<name><surname>Dietz</surname><given-names>A.</given-names></name>
<name><surname>Gerpheide</surname><given-names>S.A.</given-names></name>
<name><surname>Kuentzel</surname><given-names>S.L.</given-names></name>
<name><surname>Martin</surname><given-names>D.G.</given-names></name>
</person-group><article-title>CC-1065 (NSC-298223), a New Antitumor Antibiotic. Production, in Vitro Biological Activity, Microbiological Assays and Taxonomy of the Producing Microorganism</article-title><source>J. Antibiot.</source><year>1978</year><volume>31</volume><fpage>1211</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.31.1211</pub-id></element-citation></ref><ref id="B21-molecules-27-06387"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ichimura</surname><given-names>M.</given-names></name>
<name><surname>Ogawa</surname><given-names>T.</given-names></name>
<name><surname>Takahashi</surname><given-names>K.-I.</given-names></name>
<name><surname>Kobayashi</surname><given-names>E.</given-names></name>
<name><surname>Kawamoto</surname><given-names>I.</given-names></name>
<name><surname>Yasuzawa</surname><given-names>T.</given-names></name>
<name><surname>Takahashi</surname><given-names>I.</given-names></name>
<name><surname>Nakano</surname><given-names>H.</given-names></name>
</person-group><article-title>Duocarmycin SA, a New Antitumor Antibiotic from <italic toggle="yes">Streptomyces</italic> Sp.</article-title><source>J. Antibiot.</source><year>1990</year><volume>43</volume><fpage>1037</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.43.1037</pub-id></element-citation></ref><ref id="B22-molecules-27-06387"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martin</surname><given-names>D.G.</given-names></name>
<name><surname>Chidester</surname><given-names>C.G.</given-names></name>
<name><surname>Duchamp</surname><given-names>D.J.</given-names></name>
<name><surname>Mizsak</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Structure of CC-1065 (NSC-298223), a New Antitumor Antibiotic</article-title><source>J. Antibiot.</source><year>1980</year><volume>33</volume><fpage>902</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.33.902</pub-id></element-citation></ref><ref id="B23-molecules-27-06387"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Menderes</surname><given-names>G.</given-names></name>
<name><surname>Bonazzoli</surname><given-names>E.</given-names></name>
<name><surname>Bellone</surname><given-names>S.</given-names></name>
<name><surname>Black</surname><given-names>J.</given-names></name>
<name><surname>Predolini</surname><given-names>F.</given-names></name>
<name><surname>Pettinella</surname><given-names>F.</given-names></name>
<name><surname>Masserdotti</surname><given-names>A.</given-names></name>
<name><surname>Zammataro</surname><given-names>L.</given-names></name>
<name><surname>Altwerger</surname><given-names>G.</given-names></name>
<name><surname>Buza</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody&#x02013;Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression</article-title><source>Clin. Cancer Res.</source><year>2017</year><volume>23</volume><fpage>5836</fpage><lpage>5845</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-2862</pub-id><pub-id pub-id-type="pmid">28679774</pub-id></element-citation></ref><ref id="B24-molecules-27-06387"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerber</surname><given-names>H.-P.</given-names></name>
<name><surname>Koehn</surname><given-names>F.E.</given-names></name>
<name><surname>Abraham</surname><given-names>R.T.</given-names></name>
</person-group><article-title>The Antibody-Drug Conjugate: An Enabling Modality for Natural Product-Based Cancer Therapeutics</article-title><source>Nat. Prod. Rep.</source><year>2013</year><volume>30</volume><fpage>625</fpage><pub-id pub-id-type="doi">10.1039/c3np20113a</pub-id><pub-id pub-id-type="pmid">23525375</pub-id></element-citation></ref><ref id="B25-molecules-27-06387"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boger</surname><given-names>D.L.</given-names></name>
<name><surname>Garbaccio</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Shape-Dependent Catalysis: Insights into the Source of Catalysis for the CC-1065 and Duocarmycin DNA Alkylation Reaction</article-title><source>Acc. Chem. Res.</source><year>1999</year><volume>32</volume><fpage>1043</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1021/ar9800946</pub-id></element-citation></ref><ref id="B26-molecules-27-06387"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mullins</surname><given-names>E.A.</given-names></name>
<name><surname>Dorival</surname><given-names>J.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<name><surname>Boger</surname><given-names>D.L.</given-names></name>
<name><surname>Eichman</surname><given-names>B.F.</given-names></name>
</person-group><article-title>Structural Evolution of a DNA Repair Self-Resistance Mechanism Targeting Genotoxic Secondary Metabolites</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>6942</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-27284-7</pub-id><pub-id pub-id-type="pmid">34836957</pub-id></element-citation></ref><ref id="B27-molecules-27-06387"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Huang</surname><given-names>W.</given-names></name>
<name><surname>He</surname><given-names>Q.-L.</given-names></name>
<name><surname>Zhao</surname><given-names>Z.-X.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Kang</surname><given-names>J.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Self-Resistance to an Antitumor Antibiotic: A DNA Glycosylase Triggers the Base-Excision Repair System in Yatakemycin Biosynthesis</article-title><source>Angew. Chem. Int. Ed.</source><year>2012</year><volume>51</volume><fpage>10532</fpage><lpage>10536</lpage><pub-id pub-id-type="doi">10.1002/anie.201204109</pub-id></element-citation></ref><ref id="B28-molecules-27-06387"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mullins</surname><given-names>E.A.</given-names></name>
<name><surname>Shi</surname><given-names>R.</given-names></name>
<name><surname>Eichman</surname><given-names>B.F.</given-names></name>
</person-group><article-title>Toxicity and Repair of DNA Adducts Produced by the Natural Product Yatakemycin</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>1002</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2439</pub-id><pub-id pub-id-type="pmid">28759018</pub-id></element-citation></ref><ref id="B29-molecules-27-06387"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Cai</surname><given-names>Y.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
<name><surname>Chan</surname><given-names>H.C.S.</given-names></name>
<name><surname>Huang</surname><given-names>W.</given-names></name>
<name><surname>Jin</surname><given-names>W.-B.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Yin</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>GyrI-like Proteins Catalyze Cyclopropanoid Hydrolysis to Confer Cellular Protection</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>1485</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-01508-1</pub-id><pub-id pub-id-type="pmid">29133784</pub-id></element-citation></ref><ref id="B30-molecules-27-06387"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hurley</surname><given-names>L.H.</given-names></name>
<name><surname>Rokem</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Biosynthesis of the Antitumor Antibiotic CC-1065 by <italic toggle="yes">Streptomyces zelensis</italic></article-title><source>J. Antibiot.</source><year>1983</year><volume>36</volume><fpage>383</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.36.383</pub-id></element-citation></ref><ref id="B31-molecules-27-06387"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Jian</surname><given-names>X.-H.</given-names></name>
<name><surname>Yuan</surname><given-names>H.</given-names></name>
<name><surname>Jin</surname><given-names>W.-B.</given-names></name>
<name><surname>Yin</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>L.-Y.</given-names></name>
<name><surname>Zhao</surname><given-names>J.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Unified Biosynthetic Origin of the Benzodipyrrole Subunits in CC-1065</article-title><source>ACS Chem. Biol.</source><year>2017</year><volume>12</volume><fpage>1603</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1021/acschembio.7b00302</pub-id><pub-id pub-id-type="pmid">28426198</pub-id></element-citation></ref><ref id="B32-molecules-27-06387"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tichenor</surname><given-names>M.S.</given-names></name>
<name><surname>Boger</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Yatakemycin: Total Synthesis, DNA Alkylation, and Biological Properties</article-title><source>Nat. Prod. Rep.</source><year>2008</year><volume>25</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1039/B705665F</pub-id><?supplied-pmid 18389136?><pub-id pub-id-type="pmid">18389136</pub-id></element-citation></ref><ref id="B33-molecules-27-06387"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>W.-B.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Xu</surname><given-names>Y.-F.</given-names></name>
<name><surname>Yuan</surname><given-names>H.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Recent Advances in HemN-like Radical <italic toggle="yes">S</italic>-Adenosyl-L-Methionine Enzyme-Catalyzed Reactions</article-title><source>Nat. Prod. Rep.</source><year>2020</year><volume>37</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1039/C9NP00032A</pub-id><?supplied-pmid 31290896?><pub-id pub-id-type="pmid">31290896</pub-id></element-citation></ref><ref id="B34-molecules-27-06387"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>W.-B.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Jian</surname><given-names>X.-H.</given-names></name>
<name><surname>Yuan</surname><given-names>H.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>A Radical S-Adenosyl-L-Methionine Enzyme and a Methyltransferase Catalyze Cyclopropane Formation in Natural Product Biosynthesis</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>2771</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05217-1</pub-id><?supplied-pmid 30018376?><pub-id pub-id-type="pmid">30018376</pub-id></element-citation></ref><ref id="B35-molecules-27-06387"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
<name><surname>Rebets</surname><given-names>Y.</given-names></name>
<name><surname>Bechthold</surname><given-names>A.</given-names></name>
</person-group><article-title>Type II Polyketide Synthases: Gaining a Deeper Insight into Enzymatic Teamwork</article-title><source>Nat. Prod. Rep.</source><year>2007</year><volume>24</volume><fpage>162</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1039/B507395M</pub-id><pub-id pub-id-type="pmid">17268612</pub-id></element-citation></ref><ref id="B36-molecules-27-06387"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Das</surname><given-names>A.</given-names></name>
<name><surname>Khosla</surname><given-names>C.</given-names></name>
</person-group><article-title>Biosynthesis of Aromatic Polyketides in Bacteria</article-title><source>Acc. Chem. Res.</source><year>2009</year><volume>42</volume><fpage>631</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1021/ar8002249</pub-id><pub-id pub-id-type="pmid">19292437</pub-id></element-citation></ref><ref id="B37-molecules-27-06387"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>A.H.J.</given-names></name>
<name><surname>Ughetto</surname><given-names>G.</given-names></name>
<name><surname>Quigley</surname><given-names>G.J.</given-names></name>
<name><surname>Rich</surname><given-names>A.</given-names></name>
</person-group><article-title>Interactions between an Anthracycline Antibiotic and DNA: Molecular Structure of Daunomycin Complexed to d(CpGpTpApCpG) at 1.2-.ANG. Resolution</article-title><source>Biochemistry</source><year>1987</year><volume>26</volume><fpage>1152</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1021/bi00378a025</pub-id><pub-id pub-id-type="pmid">3567161</pub-id></element-citation></ref><ref id="B38-molecules-27-06387"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>L.D.</given-names></name>
<name><surname>Egli</surname><given-names>M.</given-names></name>
<name><surname>Qi</surname><given-names>G.</given-names></name>
<name><surname>Bash</surname><given-names>P.</given-names></name>
<name><surname>van der Marel</surname><given-names>G.A.</given-names></name>
<name><surname>van Boom</surname><given-names>J.H.</given-names></name>
<name><surname>Rich</surname><given-names>A.</given-names></name>
<name><surname>Frederick</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Structure of Nogalamycin Bound to a DNA Hexamer</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1990</year><volume>87</volume><fpage>2225</fpage><lpage>2229</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.6.2225</pub-id><pub-id pub-id-type="pmid">2315315</pub-id></element-citation></ref><ref id="B39-molecules-27-06387"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hansen</surname><given-names>M.</given-names></name>
<name><surname>Yun</surname><given-names>S.</given-names></name>
<name><surname>Hurley</surname><given-names>L.</given-names></name>
</person-group><article-title>Hedamycin Intercalates the DNA Helix and, through Carbohydrate-Mediated Recognition in the Minor Groove, Directs N7-Alkylation of Guanine in the Major Groove in a Sequence-Specific Manner</article-title><source>Chem. Biol.</source><year>1995</year><volume>2</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/1074-5521(95)90273-2</pub-id><pub-id pub-id-type="pmid">9383425</pub-id></element-citation></ref><ref id="B40-molecules-27-06387"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>D.</given-names></name>
<name><surname>Hansen</surname><given-names>M.</given-names></name>
<name><surname>Clement</surname><given-names>J.J.</given-names></name>
<name><surname>Hurley</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Structure of the Altromycin B (N7-Guanine)-DNA Adduct. A Proposed Prototypic DNA Adduct Structure for the Pluramycin Antitumor Antibiotics</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>8068</fpage><lpage>8074</lpage><pub-id pub-id-type="doi">10.1021/bi00083a003</pub-id><pub-id pub-id-type="pmid">8347608</pub-id></element-citation></ref><ref id="B41-molecules-27-06387"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pavlopoulos</surname><given-names>S.</given-names></name>
<name><surname>Bicknell</surname><given-names>W.</given-names></name>
<name><surname>Wickham</surname><given-names>G.</given-names></name>
<name><surname>Craik</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Characterization of the Sequential Non-Covalent and Covalent Interactions of the Antitumour Antibiotic Hedamycin with Double Stranded DNA by NMR Spectroscopy</article-title><source>J. Mol. Recognit.</source><year>1999</year><volume>12</volume><fpage>346</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1352(199911/12)12:6&#x0003c;346::AID-JMR476&#x0003e;3.0.CO;2-L</pub-id><pub-id pub-id-type="pmid">10611644</pub-id></element-citation></ref><ref id="B42-molecules-27-06387"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bililign</surname><given-names>T.</given-names></name>
<name><surname>Griffith</surname><given-names>B.R.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Structure, Activity, Synthesis and Biosynthesis of Aryl-C-Glycosides</article-title><source>Nat. Prod. Rep.</source><year>2005</year><volume>22</volume><fpage>742</fpage><pub-id pub-id-type="doi">10.1039/b407364a</pub-id><pub-id pub-id-type="pmid">16311633</pub-id></element-citation></ref><ref id="B43-molecules-27-06387"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Das</surname><given-names>A.</given-names></name>
<name><surname>Khosla</surname><given-names>C.</given-names></name>
</person-group><article-title>In Vivo and In Vitro Analysis of the Hedamycin Polyketide Synthase</article-title><source>Chem. Biol.</source><year>2009</year><volume>16</volume><fpage>1197</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2009.11.005</pub-id><pub-id pub-id-type="pmid">19942143</pub-id></element-citation></ref><ref id="B44-molecules-27-06387"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bililign</surname><given-names>T.</given-names></name>
<name><surname>Hyun</surname><given-names>C.-G.</given-names></name>
<name><surname>Williams</surname><given-names>J.S.</given-names></name>
<name><surname>Czisny</surname><given-names>A.M.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
</person-group><article-title>The Hedamycin Locus Implicates a Novel Aromatic PKS Priming Mechanism</article-title><source>Chem. Biol.</source><year>2004</year><volume>11</volume><fpage>959</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2004.04.016</pub-id><pub-id pub-id-type="pmid">15271354</pub-id></element-citation></ref><ref id="B45-molecules-27-06387"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Hou</surname><given-names>X.-F.</given-names></name>
<name><surname>Qi</surname><given-names>L.-H.</given-names></name>
<name><surname>Yin</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Pan</surname><given-names>H.-X.</given-names></name>
<name><surname>Chen</surname><given-names>X.-Y.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Biosynthesis of Trioxacarcin Revealing a Different Starter Unit and Complex Tailoring Steps for Type II Polyketide Synthase</article-title><source>Chem. Sci.</source><year>2015</year><volume>6</volume><fpage>3440</fpage><lpage>3447</lpage><pub-id pub-id-type="doi">10.1039/C5SC00116A</pub-id><pub-id pub-id-type="pmid">29511509</pub-id></element-citation></ref><ref id="B46-molecules-27-06387"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pfoh</surname><given-names>R.</given-names></name>
<name><surname>Laatsch</surname><given-names>H.</given-names></name>
<name><surname>Sheldrick</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Crystal Structure of Trioxacarcin A Covalently Bound to DNA</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>3508</fpage><lpage>3514</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn245</pub-id><pub-id pub-id-type="pmid">18453630</pub-id></element-citation></ref><ref id="B47-molecules-27-06387"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>L.</given-names></name>
<name><surname>Shen</surname><given-names>Y.</given-names></name>
<name><surname>Hou</surname><given-names>X.-F.</given-names></name>
<name><surname>Li</surname><given-names>W.-J.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Discovery of Druggability-Improved Analogues by Investigation of the LL-D49194&#x003b1;1 Biosynthetic Pathway</article-title><source>Org. Lett.</source><year>2019</year><volume>21</volume><fpage>2322</fpage><lpage>2325</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.9b00610</pub-id><pub-id pub-id-type="pmid">30855966</pub-id></element-citation></ref><ref id="B48-molecules-27-06387"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pr&#x000f6;pper</surname><given-names>K.</given-names></name>
<name><surname>Dittrich</surname><given-names>B.</given-names></name>
<name><surname>Smaltz</surname><given-names>D.J.</given-names></name>
<name><surname>Magauer</surname><given-names>T.</given-names></name>
<name><surname>Myers</surname><given-names>A.G.</given-names></name>
</person-group><article-title>Crystalline Guanine Adducts of Natural and Synthetic Trioxacarcins Suggest a Common Biological Mechanism and Reveal a Basis for the Instability of Trioxacarcin A</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2014</year><volume>24</volume><fpage>4410</fpage><lpage>4413</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2014.08.016</pub-id><pub-id pub-id-type="pmid">25176186</pub-id></element-citation></ref><ref id="B49-molecules-27-06387"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fitzner</surname><given-names>A.</given-names></name>
<name><surname>Frauendorf</surname><given-names>H.</given-names></name>
<name><surname>Laatsch</surname><given-names>H.</given-names></name>
<name><surname>Diederichsen</surname><given-names>U.</given-names></name>
</person-group><article-title>Formation of Gutingimycin: Analytical Investigation of Trioxacarcin A-Mediated Alkylation of DsDNA</article-title><source>Anal. Bioanal. Chem.</source><year>2008</year><volume>390</volume><fpage>1139</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1007/s00216-007-1737-6</pub-id><pub-id pub-id-type="pmid">18210096</pub-id></element-citation></ref><ref id="B50-molecules-27-06387"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Bradley</surname><given-names>N.P.</given-names></name>
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Wahl</surname><given-names>K.L.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Yuan</surname><given-names>H.</given-names></name>
<name><surname>Hou</surname><given-names>X.-F.</given-names></name>
<name><surname>Eichman</surname><given-names>B.F.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Base Excision Repair System Targeting DNA Adducts of Trioxacarcin/LL-D49194 Antibiotics for Self-Resistance</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>2417</fpage><lpage>2430</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac085</pub-id><pub-id pub-id-type="pmid">35191495</pub-id></element-citation></ref><ref id="B51-molecules-27-06387"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hou</surname><given-names>X.-F.</given-names></name>
<name><surname>Song</surname><given-names>Y.-J.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Lan</surname><given-names>W.</given-names></name>
<name><surname>Meng</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Pan</surname><given-names>H.-X.</given-names></name>
<name><surname>Cao</surname><given-names>C.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Enzymology of Anthraquinone-&#x003b3;-Pyrone Ring Formation in Complex Aromatic Polyketide Biosynthesis</article-title><source>Angew. Chem. Int. Ed.</source><year>2018</year><volume>57</volume><fpage>13475</fpage><lpage>13479</lpage><pub-id pub-id-type="doi">10.1002/anie.201806729</pub-id></element-citation></ref><ref id="B52-molecules-27-06387"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yin</surname><given-names>Y.</given-names></name>
<name><surname>Shen</surname><given-names>Y.</given-names></name>
<name><surname>Meng</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Pan</surname><given-names>H.</given-names></name>
<name><surname>Tang</surname><given-names>G.</given-names></name>
</person-group><article-title>Characterization of a Membrane-Bound <italic toggle="yes">O</italic>-acetyltransferase Involved in Trioxacarcin Biosynthesis Offers Insights into Its Catalytic Mechanism</article-title><source>Chin. J. Chem.</source><year>2020</year><volume>38</volume><fpage>1607</fpage><lpage>1611</lpage><pub-id pub-id-type="doi">10.1002/cjoc.202000284</pub-id></element-citation></ref><ref id="B53-molecules-27-06387"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bass</surname><given-names>P.D.</given-names></name>
<name><surname>Gubler</surname><given-names>D.A.</given-names></name>
<name><surname>Judd</surname><given-names>T.C.</given-names></name>
<name><surname>Williams</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Mitomycinoid Alkaloids: Mechanism of Action, Biosynthesis, Total Syntheses, and Synthetic Approaches</article-title><source>Chem. Rev.</source><year>2013</year><volume>113</volume><fpage>6816</fpage><lpage>6863</lpage><pub-id pub-id-type="doi">10.1021/cr3001059</pub-id><pub-id pub-id-type="pmid">23654296</pub-id></element-citation></ref><ref id="B54-molecules-27-06387"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suresh Kumar</surname><given-names>G.</given-names></name>
<name><surname>Lipman</surname><given-names>R.</given-names></name>
<name><surname>Cummings</surname><given-names>J.</given-names></name>
<name><surname>Tomasz</surname><given-names>M.</given-names></name>
</person-group><article-title>Mitomycin C&#x02212;DNA Adducts Generated by DT-Diaphorase. Revised Mechanism of the Enzymatic Reductive Activation of Mitomycin C</article-title><source>Biochemistry</source><year>1997</year><volume>36</volume><fpage>14128</fpage><lpage>14136</lpage><pub-id pub-id-type="doi">10.1021/bi971394i</pub-id><pub-id pub-id-type="pmid">9369485</pub-id></element-citation></ref><ref id="B55-molecules-27-06387"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hirai</surname><given-names>O.</given-names></name>
<name><surname>Shimomura</surname><given-names>K.</given-names></name>
<name><surname>Mizota</surname><given-names>T.</given-names></name>
<name><surname>Matsumoto</surname><given-names>S.</given-names></name>
<name><surname>Mori</surname><given-names>J.</given-names></name>
<name><surname>Kikuchi</surname><given-names>H.</given-names></name>
</person-group><article-title>A New Antitumor Antibiotic, FR-900482. IV. Hematological Toxicity in Mice</article-title><source>J. Antibiot.</source><year>1987</year><volume>40</volume><fpage>607</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.40.607</pub-id></element-citation></ref><ref id="B56-molecules-27-06387"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>August</surname><given-names>P.R.</given-names></name>
<name><surname>Flickinger</surname><given-names>M.C.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Cloning and Analysis of a Locus (Mcr) Involved in Mitomycin C Resistance in <italic toggle="yes">Streptomyces lavendulae</italic></article-title><source>J. Bacteriol.</source><year>1994</year><volume>176</volume><fpage>4448</fpage><lpage>4454</lpage><pub-id pub-id-type="doi">10.1128/jb.176.14.4448-4454.1994</pub-id><pub-id pub-id-type="pmid">7517396</pub-id></element-citation></ref><ref id="B57-molecules-27-06387"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sheldon</surname><given-names>P.J.</given-names></name>
<name><surname>Johnson</surname><given-names>D.A.</given-names></name>
<name><surname>August</surname><given-names>P.R.</given-names></name>
<name><surname>Liu</surname><given-names>H.W.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Characterization of a Mitomycin-Binding Drug Resistance Mechanism from the Producing Organism, <italic toggle="yes">Streptomyces lavendulae</italic></article-title><source>J. Bacteriol.</source><year>1997</year><volume>179</volume><fpage>1796</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.1128/jb.179.5.1796-1804.1997</pub-id><pub-id pub-id-type="pmid">9045843</pub-id></element-citation></ref><ref id="B58-molecules-27-06387"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>D.A.</given-names></name>
<name><surname>August</surname><given-names>P.R.</given-names></name>
<name><surname>Shackleton</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Microbial Resistance to Mitomycins Involves a Redox Relay Mechanism</article-title><source>J. Am. Chem. Soc.</source><year>1997</year><volume>119</volume><fpage>2576</fpage><lpage>2577</lpage><pub-id pub-id-type="doi">10.1021/ja963880j</pub-id></element-citation></ref><ref id="B59-molecules-27-06387"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>M.</given-names></name>
<name><surname>Sheldon</surname><given-names>P.J.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Characterization of a Quinone Reductase Activity for the Mitomycin C Binding Protein (MRD): Functional Switching from a Drug-Activating Enzyme to a Drug-Binding Protein</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>926</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1073/pnas.98.3.926</pub-id><pub-id pub-id-type="pmid">11158572</pub-id></element-citation></ref><ref id="B60-molecules-27-06387"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Namiki</surname><given-names>H.</given-names></name>
<name><surname>Chamberland</surname><given-names>S.</given-names></name>
<name><surname>Gubler</surname><given-names>D.A.</given-names></name>
<name><surname>Williams</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Synthetic and Biosynthetic Studies on FR900482 and Mitomycin C: An Efficient and Stereoselective Hydroxymethylation of an Advanced Benzazocane Intermediate</article-title><source>Org. Lett.</source><year>2007</year><volume>9</volume><fpage>5341</fpage><lpage>5344</lpage><pub-id pub-id-type="doi">10.1021/ol701960v</pub-id><pub-id pub-id-type="pmid">18047354</pub-id></element-citation></ref><ref id="B61-molecules-27-06387"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hornemann</surname><given-names>U.</given-names></name>
<name><surname>Kehrer</surname><given-names>J.P.</given-names></name>
<name><surname>Nunez</surname><given-names>C.S.</given-names></name>
<name><surname>Ranieri</surname><given-names>R.L.</given-names></name>
</person-group><article-title>D-Glucosamine and L-Citrulline, Precursors in Mitomycin Biosynthesis by <italic toggle="yes">Streptomyces verticillatus</italic></article-title><source>J. Am. Chem. Soc.</source><year>1974</year><volume>96</volume><fpage>320</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1021/ja00808a087</pub-id><pub-id pub-id-type="pmid">4810575</pub-id></element-citation></ref><ref id="B62-molecules-27-06387"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mao</surname><given-names>Y.</given-names></name>
<name><surname>Varoglu</surname><given-names>M.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Molecular Characterization and Analysis of the Biosynthetic Gene Cluster for the Antitumor Antibiotic Mitomycin C from <italic toggle="yes">Streptomyces lavendulae</italic> NRRL 2564</article-title><source>Chem. Biol.</source><year>1999</year><volume>6</volume><fpage>251</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(99)80040-4</pub-id><pub-id pub-id-type="pmid">10099135</pub-id></element-citation></ref><ref id="B63-molecules-27-06387"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>C.-G.</given-names></name>
<name><surname>Yu</surname><given-names>T.-W.</given-names></name>
<name><surname>Fryhle</surname><given-names>C.B.</given-names></name>
<name><surname>Handa</surname><given-names>S.</given-names></name>
<name><surname>Floss</surname><given-names>H.G.</given-names></name>
</person-group><article-title>3-Amino-5-Hydroxybenzoic Acid Synthase, the Terminal Enzyme in the Formation of the Precursor of MC7N Units in Rifamycin and Related Antibiotics</article-title><source>J. Biol. Chem.</source><year>1998</year><volume>273</volume><fpage>6030</fpage><lpage>6040</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.11.6030</pub-id><?supplied-pmid 9497318?><pub-id pub-id-type="pmid">9497318</pub-id></element-citation></ref><ref id="B64-molecules-27-06387"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>J.</given-names></name>
<name><surname>Frost</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Kanosamine Biosynthesis: A Likely Source of the Aminoshikimate Pathway&#x02019;s Nitrogen Atom</article-title><source>J. Am. Chem. Soc.</source><year>2002</year><volume>124</volume><fpage>10642</fpage><lpage>10643</lpage><pub-id pub-id-type="doi">10.1021/ja026628m</pub-id><?supplied-pmid 12207504?><pub-id pub-id-type="pmid">12207504</pub-id></element-citation></ref><ref id="B65-molecules-27-06387"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>H.P.</given-names></name>
<name><surname>Yokoyama</surname><given-names>K.</given-names></name>
</person-group><article-title>Characterization of Acyl Carrier Protein-Dependent Glycosyltransferase in Mitomycin C Biosynthesis</article-title><source>Biochemistry</source><year>2019</year><volume>58</volume><fpage>2804</fpage><lpage>2808</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b00379</pub-id><pub-id pub-id-type="pmid">31188570</pub-id></element-citation></ref><ref id="B66-molecules-27-06387"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thibodeaux</surname><given-names>C.J.</given-names></name>
<name><surname>Chang</surname><given-names>W.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
</person-group><article-title>Enzymatic Chemistry of Cyclopropane, Epoxide, and Aziridine Biosynthesis</article-title><source>Chem. Rev.</source><year>2012</year><volume>112</volume><fpage>1681</fpage><lpage>1709</lpage><pub-id pub-id-type="doi">10.1021/cr200073d</pub-id><pub-id pub-id-type="pmid">22017381</pub-id></element-citation></ref><ref id="B67-molecules-27-06387"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ogasawara</surname><given-names>Y.</given-names></name>
<name><surname>Nakagawa</surname><given-names>Y.</given-names></name>
<name><surname>Maruyama</surname><given-names>C.</given-names></name>
<name><surname>Hamano</surname><given-names>Y.</given-names></name>
<name><surname>Dairi</surname><given-names>T.</given-names></name>
</person-group><article-title>In Vitro Characterization of MitE and MitB: Formation of N-Acetylglucosaminyl-3-Amino-5-Hydroxybenzoyl-MmcB as a Key Intermediate in the Biosynthesis of Antitumor Antibiotic Mitomycins</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2019</year><volume>29</volume><fpage>2076</fpage><lpage>2078</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2019.07.009</pub-id><pub-id pub-id-type="pmid">31300341</pub-id></element-citation></ref><ref id="B68-molecules-27-06387"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Cheng</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>W.</given-names></name>
</person-group><article-title>Tracing of Acyl Carrier Protein-Channeled Mitomycin Intermediates in <italic toggle="yes">Streptomyces caespitosus</italic> Facilitates Characterization of the Biosynthetic Steps for AHBA&#x02013;GlcN Formation and Processing</article-title><source>J. Am. Chem. Soc.</source><year>2022</year><volume>144</volume><fpage>14945</fpage><lpage>14956</lpage><pub-id pub-id-type="doi">10.1021/jacs.2c06969</pub-id><pub-id pub-id-type="pmid">35943208</pub-id></element-citation></ref><ref id="B69-molecules-27-06387"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gr&#x000fc;schow</surname><given-names>S.</given-names></name>
<name><surname>Chang</surname><given-names>L.-C.</given-names></name>
<name><surname>Mao</surname><given-names>Y.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Hydroxyquinone O-Methylation in Mitomycin Biosynthesis</article-title><source>J. Am. Chem. Soc.</source><year>2007</year><volume>129</volume><fpage>6470</fpage><lpage>6476</lpage><pub-id pub-id-type="doi">10.1021/ja0700193</pub-id><pub-id pub-id-type="pmid">17461583</pub-id></element-citation></ref><ref id="B70-molecules-27-06387"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Varoglu</surname><given-names>M.</given-names></name>
<name><surname>Mao</surname><given-names>Y.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Mapping the Mitomycin Biosynthetic Pathway by Functional Analysis of the MitM Aziridine <italic toggle="yes">N</italic> -Methyltransferase</article-title><source>J. Am. Chem. Soc.</source><year>2001</year><volume>123</volume><fpage>6712</fpage><lpage>6713</lpage><pub-id pub-id-type="doi">10.1021/ja015646l</pub-id><pub-id pub-id-type="pmid">11439066</pub-id></element-citation></ref><ref id="B71-molecules-27-06387"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foulke-Abel</surname><given-names>J.</given-names></name>
<name><surname>Agbo</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Mori</surname><given-names>S.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Mode of Action and Biosynthesis of the Azabicycle-Containing Natural Products Azinomycin and Ficellomycin</article-title><source>Nat. Prod. Rep.</source><year>2011</year><volume>28</volume><fpage>693</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1039/c0np00049c</pub-id><pub-id pub-id-type="pmid">21327255</pub-id></element-citation></ref><ref id="B72-molecules-27-06387"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zang</surname><given-names>H.</given-names></name>
<name><surname>Gates</surname><given-names>K.S.</given-names></name>
</person-group><article-title>DNA Binding and Alkylation by the &#x0201c;Left Half&#x0201d; of Azinomycin B</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>14968</fpage><lpage>14975</lpage><pub-id pub-id-type="doi">10.1021/bi001998d</pub-id><pub-id pub-id-type="pmid">11101313</pub-id></element-citation></ref><ref id="B73-molecules-27-06387"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alcaro</surname><given-names>S.</given-names></name>
<name><surname>Ortuso</surname><given-names>F.</given-names></name>
<name><surname>Coleman</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Molecular Modeling of DNA Cross-Linking Analogues Based on the Azinomycin Scaffold</article-title><source>J. Chem. Inf. Model.</source><year>2005</year><volume>45</volume><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1021/ci0496595</pub-id><pub-id pub-id-type="pmid">15921450</pub-id></element-citation></ref><ref id="B74-molecules-27-06387"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coleman</surname><given-names>R.S.</given-names></name>
<name><surname>Perez</surname><given-names>R.J.</given-names></name>
<name><surname>Burk</surname><given-names>C.H.</given-names></name>
<name><surname>Navarro</surname><given-names>A.</given-names></name>
</person-group><article-title>Studies on the Mechanism of Action of Azinomycin B: Definition of Regioselectivity and Sequence Selectivity of DNA Cross-Link Formation and Clarification of the Role of the Naphthoate</article-title><source>J. Am. Chem. Soc.</source><year>2002</year><volume>124</volume><fpage>13008</fpage><lpage>13017</lpage><pub-id pub-id-type="doi">10.1021/ja025563k</pub-id><pub-id pub-id-type="pmid">12405827</pub-id></element-citation></ref><ref id="B75-molecules-27-06387"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foulke-Abel</surname><given-names>J.</given-names></name>
<name><surname>Kelly</surname><given-names>G.T.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Characterization of AziR, a Resistance Protein of the DNA Cross-Linking Agent Azinomycin B</article-title><source>Mol. BioSyst.</source><year>2011</year><volume>7</volume><fpage>2563</fpage><pub-id pub-id-type="doi">10.1039/c1mb05136a</pub-id><pub-id pub-id-type="pmid">21776524</pub-id></element-citation></ref><ref id="B76-molecules-27-06387"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>K.</given-names></name>
<name><surname>Xiao</surname><given-names>L.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Lei</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Feng</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Characterization of a Novel DNA Glycosylase from <italic toggle="yes">S. sahachiroi</italic> Involved in the Reduction and Repair of Azinomycin B Induced DNA Damage</article-title><source>Nucleic Acids Res.</source><year>2016</year><volume>44</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv949</pub-id><pub-id pub-id-type="pmid">26400161</pub-id></element-citation></ref><ref id="B77-molecules-27-06387"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Ying</surname><given-names>K.</given-names></name>
<name><surname>Xiao</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>K.</given-names></name>
<name><surname>Zuo</surname><given-names>X.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
</person-group><article-title>Identification of a Novel Structure-Specific Endonuclease AziN That Contributes to the Repair of Azinomycin B-Mediated DNA Interstrand Crosslinks</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>709</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1067</pub-id><pub-id pub-id-type="pmid">31713613</pub-id></element-citation></ref><ref id="B78-molecules-27-06387"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mullins</surname><given-names>E.A.</given-names></name>
<name><surname>Warren</surname><given-names>G.M.</given-names></name>
<name><surname>Bradley</surname><given-names>N.P.</given-names></name>
<name><surname>Eichman</surname><given-names>B.F.</given-names></name>
</person-group><article-title>Structure of a DNA Glycosylase That Unhooks Interstrand Cross-Links</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>4400</fpage><lpage>4405</lpage><pub-id pub-id-type="doi">10.1073/pnas.1703066114</pub-id><pub-id pub-id-type="pmid">28396405</pub-id></element-citation></ref><ref id="B79-molecules-27-06387"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>G.T.</given-names></name>
<name><surname>Sharma</surname><given-names>V.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>An Improved Method for Culturing <italic toggle="yes">Streptomyces sahachiroi</italic>: Biosynthetic Origin of the Enol Fragment of Azinomycin B</article-title><source>Bioorg. Chem.</source><year>2008</year><volume>36</volume><fpage>4</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2007.08.002</pub-id><pub-id pub-id-type="pmid">17904193</pub-id></element-citation></ref><ref id="B80-molecules-27-06387"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelly</surname><given-names>G.T.</given-names></name>
<name><surname>Washburn</surname><given-names>L.A.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>The Fate of Molecular Oxygen in Azinomycin Biosynthesis</article-title><source>J. Org. Chem.</source><year>2019</year><volume>84</volume><fpage>2991</fpage><lpage>2996</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.8b03007</pub-id><pub-id pub-id-type="pmid">30680995</pub-id></element-citation></ref><ref id="B81-molecules-27-06387"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>V.</given-names></name>
<name><surname>Kelly</surname><given-names>G.T.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Exploration of the Molecular Origin of the Azinomycin Epoxide: Timing of the Biosynthesis Revealed</article-title><source>Org. Lett.</source><year>2008</year><volume>10</volume><fpage>4815</fpage><lpage>4818</lpage><pub-id pub-id-type="doi">10.1021/ol8018852</pub-id><pub-id pub-id-type="pmid">18841989</pub-id></element-citation></ref><ref id="B82-molecules-27-06387"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Q.</given-names></name>
<name><surname>He</surname><given-names>Q.</given-names></name>
<name><surname>Ding</surname><given-names>W.</given-names></name>
<name><surname>Tang</surname><given-names>M.</given-names></name>
<name><surname>Kang</surname><given-names>Q.</given-names></name>
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Deng</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Fang</surname><given-names>J.</given-names></name>
<name><surname>Tang</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Characterization of the Azinomycin B Biosynthetic Gene Cluster Revealing a Different Iterative Type I Polyketide Synthase for Naphthoate Biosynthesis</article-title><source>Chem. Biol.</source><year>2008</year><volume>15</volume><fpage>693</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2008.05.021</pub-id><pub-id pub-id-type="pmid">18635006</pub-id></element-citation></ref><ref id="B83-molecules-27-06387"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mori</surname><given-names>S.</given-names></name>
<name><surname>Simkhada</surname><given-names>D.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Erb</surname><given-names>M.S.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Williams</surname><given-names>H.</given-names></name>
<name><surname>Fedoseyenko</surname><given-names>D.</given-names></name>
<name><surname>Russell</surname><given-names>W.K.</given-names></name>
<name><surname>Kim</surname><given-names>D.</given-names></name>
<name><surname>Fleer</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Polyketide Ring Expansion Mediated by a Thioesterase, Chain Elongation and Cyclization Domain, in Azinomycin Biosynthesis: Characterization of AziB and AziG</article-title><source>Biochemistry</source><year>2016</year><volume>55</volume><fpage>704</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.5b01050</pub-id><pub-id pub-id-type="pmid">26731610</pub-id></element-citation></ref><ref id="B84-molecules-27-06387"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>W.</given-names></name>
<name><surname>Deng</surname><given-names>W.</given-names></name>
<name><surname>Tang</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Tang</surname><given-names>G.</given-names></name>
<name><surname>Bi</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>W.</given-names></name>
</person-group><article-title>Biosynthesis of 3-Methoxy-5-Methyl Naphthoic Acid and Its Incorporation into the Antitumor Antibiotic Azinomycin B</article-title><source>Mol. BioSyst.</source><year>2010</year><volume>6</volume><fpage>1071</fpage><pub-id pub-id-type="doi">10.1039/b926358f</pub-id><pub-id pub-id-type="pmid">20485749</pub-id></element-citation></ref><ref id="B85-molecules-27-06387"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miyashita</surname><given-names>K.</given-names></name>
<name><surname>Park</surname><given-names>M.</given-names></name>
<name><surname>Adachi</surname><given-names>S.</given-names></name>
<name><surname>Seki</surname><given-names>S.</given-names></name>
<name><surname>Obika</surname><given-names>S.</given-names></name>
<name><surname>Imanishi</surname><given-names>T.</given-names></name>
</person-group><article-title>A 3,4-Epoxypiperidine Structure as a Novel and Simple DNA-Cleavage Unit</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2002</year><volume>12</volume><fpage>1075</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(02)00085-9</pub-id><pub-id pub-id-type="pmid">11909721</pub-id></element-citation></ref><ref id="B86-molecules-27-06387"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nepal</surname><given-names>K.K.</given-names></name>
<name><surname>Lee</surname><given-names>R.P.</given-names></name>
<name><surname>Rezenom</surname><given-names>Y.H.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Probing the Role of <italic toggle="yes">N</italic> -Acetyl-Glutamyl 5-Phosphate, an Acyl Phosphate, in the Construction of the Azabicycle Moiety of the Azinomycins</article-title><source>Biochemistry</source><year>2015</year><volume>54</volume><fpage>4415</fpage><lpage>4418</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.5b00711</pub-id><pub-id pub-id-type="pmid">26161634</pub-id></element-citation></ref><ref id="B87-molecules-27-06387"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mori</surname><given-names>S.</given-names></name>
<name><surname>Nepal</surname><given-names>K.K.</given-names></name>
<name><surname>Kelly</surname><given-names>G.T.</given-names></name>
<name><surname>Sharma</surname><given-names>V.</given-names></name>
<name><surname>Simkhada</surname><given-names>D.</given-names></name>
<name><surname>Gowda</surname><given-names>V.</given-names></name>
<name><surname>Delgado</surname><given-names>D.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Priming of Azabicycle Biosynthesis in the Azinomycin Class of Antitumor Agents</article-title><source>Biochemistry</source><year>2017</year><volume>56</volume><fpage>805</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.6b01108</pub-id><pub-id pub-id-type="pmid">28135072</pub-id></element-citation></ref><ref id="B88-molecules-27-06387"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Washburn</surname><given-names>L.A.</given-names></name>
<name><surname>Foley</surname><given-names>B.</given-names></name>
<name><surname>Martinez</surname><given-names>F.</given-names></name>
<name><surname>Lee</surname><given-names>R.P.</given-names></name>
<name><surname>Pryor</surname><given-names>K.</given-names></name>
<name><surname>Rimes</surname><given-names>E.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Transketolase Activity in the Formation of the Azinomycin Azabicycle Moiety</article-title><source>Biochemistry</source><year>2019</year><volume>58</volume><fpage>5255</fpage><lpage>5258</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b00477</pub-id><pub-id pub-id-type="pmid">31424204</pub-id></element-citation></ref><ref id="B89-molecules-27-06387"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kurosawa</surname><given-names>S.</given-names></name>
<name><surname>Hasebe</surname><given-names>F.</given-names></name>
<name><surname>Okamura</surname><given-names>H.</given-names></name>
<name><surname>Yoshida</surname><given-names>A.</given-names></name>
<name><surname>Matsuda</surname><given-names>K.</given-names></name>
<name><surname>Sone</surname><given-names>Y.</given-names></name>
<name><surname>Tomita</surname><given-names>T.</given-names></name>
<name><surname>Shinada</surname><given-names>T.</given-names></name>
<name><surname>Takikawa</surname><given-names>H.</given-names></name>
<name><surname>Kuzuyama</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Molecular Basis for Enzymatic Aziridine Formation via Sulfate Elimination</article-title><source>J. Am. Chem. Soc.</source><year>2022</year><volume>144</volume><fpage>16164</fpage><lpage>16170</lpage><pub-id pub-id-type="doi">10.1021/jacs.2c07243</pub-id><?supplied-pmid 35998388?><pub-id pub-id-type="pmid">35998388</pub-id></element-citation></ref><ref id="B90-molecules-27-06387"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hasebe</surname><given-names>F.</given-names></name>
<name><surname>Matsuda</surname><given-names>K.</given-names></name>
<name><surname>Shiraishi</surname><given-names>T.</given-names></name>
<name><surname>Futamura</surname><given-names>Y.</given-names></name>
<name><surname>Nakano</surname><given-names>T.</given-names></name>
<name><surname>Tomita</surname><given-names>T.</given-names></name>
<name><surname>Ishigami</surname><given-names>K.</given-names></name>
<name><surname>Taka</surname><given-names>H.</given-names></name>
<name><surname>Mineki</surname><given-names>R.</given-names></name>
<name><surname>Fujimura</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Amino-Group Carrier-Protein-Mediated Secondary Metabolite Biosynthesis in Streptomyces</article-title><source>Nat. Chem. Biol.</source><year>2016</year><volume>12</volume><fpage>967</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2181</pub-id><?supplied-pmid 28288097?><pub-id pub-id-type="pmid">28288097</pub-id></element-citation></ref><ref id="B91-molecules-27-06387"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>V.</given-names></name>
<name><surname>Kelly</surname><given-names>G.T.</given-names></name>
<name><surname>Foulke-Abel</surname><given-names>J.</given-names></name>
<name><surname>Watanabe</surname><given-names>C.M.H.</given-names></name>
</person-group><article-title>Aminoacetone as the Penultimate Precursor to the Antitumor Agent Azinomycin A</article-title><source>Org. Lett.</source><year>2009</year><volume>11</volume><fpage>4006</fpage><lpage>4009</lpage><pub-id pub-id-type="doi">10.1021/ol9016639</pub-id><?supplied-pmid 19663419?><pub-id pub-id-type="pmid">19663419</pub-id></element-citation></ref><ref id="B92-molecules-27-06387"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Antonow</surname><given-names>D.</given-names></name>
<name><surname>Thurston</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Synthesis of DNA-Interactive Pyrrolo [2,1-<italic toggle="yes">c</italic>][1,4]Benzodiazepines (PBDs)</article-title><source>Chem. Rev.</source><year>2011</year><volume>111</volume><fpage>2815</fpage><lpage>2864</lpage><pub-id pub-id-type="doi">10.1021/cr100120f</pub-id><pub-id pub-id-type="pmid">21166464</pub-id></element-citation></ref><ref id="B93-molecules-27-06387"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerratana</surname><given-names>B.</given-names></name>
</person-group><article-title>Biosynthesis, Synthesis, and Biological Activities of Pyrrolobenzodiazepines: Activities of Pyrrolobenzodiazepines</article-title><source>Med. Res. Rev.</source><year>2012</year><volume>32</volume><fpage>254</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1002/med.20212</pub-id><pub-id pub-id-type="pmid">20544978</pub-id></element-citation></ref><ref id="B94-molecules-27-06387"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barkley</surname><given-names>M.D.</given-names></name>
<name><surname>Cheatham</surname><given-names>S.</given-names></name>
<name><surname>Thurston</surname><given-names>D.E.</given-names></name>
<name><surname>Hurley</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Pyrrolo[1,4]Benzodiazepine Antitumor Antibiotics: Evidence for Two Forms of Tomaymycin Bound to DNA</article-title><source>Biochemistry</source><year>1986</year><volume>25</volume><fpage>3021</fpage><lpage>3031</lpage><pub-id pub-id-type="doi">10.1021/bi00358a043</pub-id><pub-id pub-id-type="pmid">3718937</pub-id></element-citation></ref><ref id="B95-molecules-27-06387"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kopka</surname><given-names>M.L.</given-names></name>
<name><surname>Goodsell</surname><given-names>D.S.</given-names></name>
<name><surname>Baikalov</surname><given-names>I.</given-names></name>
<name><surname>Grzeskowiak</surname><given-names>K.</given-names></name>
<name><surname>Cascio</surname><given-names>D.</given-names></name>
<name><surname>Dickerson</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Crystal Structure of a Covalent DNA-Drug Adduct: Anthramycin Bound to C-C-A-A-C-G-T-T-G-G and a Molecular Explanation of Specificity</article-title><source>Biochemistry</source><year>1994</year><volume>33</volume><fpage>13593</fpage><lpage>13610</lpage><pub-id pub-id-type="doi">10.1021/bi00250a011</pub-id><pub-id pub-id-type="pmid">7947769</pub-id></element-citation></ref><ref id="B96-molecules-27-06387"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arora</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Structure of Tomaymycin, a DNA Binding Antitumor Antibiotic</article-title><source>J. Antibiot.</source><year>1981</year><volume>34</volume><fpage>462</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.34.462</pub-id></element-citation></ref><ref id="B97-molecules-27-06387"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>A.D.</given-names></name>
<name><surname>Tomasi</surname><given-names>S.</given-names></name>
<name><surname>Tiberghien</surname><given-names>A.C.</given-names></name>
<name><surname>Parker</surname><given-names>J.S.</given-names></name>
</person-group><article-title>An Isomerization Approach to Tesirine and Pyrrolobenzodiazepines</article-title><source>Org. Process Res. Dev.</source><year>2019</year><volume>23</volume><fpage>2543</fpage><lpage>2548</lpage><pub-id pub-id-type="doi">10.1021/acs.oprd.9b00332</pub-id></element-citation></ref><ref id="B98-molecules-27-06387"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mantaj</surname><given-names>J.</given-names></name>
<name><surname>Jackson</surname><given-names>P.J.M.</given-names></name>
<name><surname>Rahman</surname><given-names>K.M.</given-names></name>
<name><surname>Thurston</surname><given-names>D.E.</given-names></name>
</person-group><article-title>From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs)</article-title><source>Angew. Chem. Int. Ed.</source><year>2017</year><volume>56</volume><fpage>462</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1002/anie.201510610</pub-id></element-citation></ref><ref id="B99-molecules-27-06387"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Khullar</surname><given-names>A.</given-names></name>
<name><surname>Chou</surname><given-names>S.</given-names></name>
<name><surname>Sacramo</surname><given-names>A.</given-names></name>
<name><surname>Gerratana</surname><given-names>B.</given-names></name>
</person-group><article-title>Biosynthesis of Sibiromycin, a Potent Antitumor Antibiotic</article-title><source>Appl. Environ. Microbiol.</source><year>2009</year><volume>75</volume><fpage>2869</fpage><lpage>2878</lpage><pub-id pub-id-type="doi">10.1128/AEM.02326-08</pub-id><pub-id pub-id-type="pmid">19270142</pub-id></element-citation></ref><ref id="B100-molecules-27-06387"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kamenik</surname><given-names>Z.</given-names></name>
<name><surname>Gazak</surname><given-names>R.</given-names></name>
<name><surname>Kadlcik</surname><given-names>S.</given-names></name>
<name><surname>Steiningerova</surname><given-names>L.</given-names></name>
<name><surname>Rynd</surname><given-names>V.</given-names></name>
<name><surname>Janata</surname><given-names>J.</given-names></name>
</person-group><article-title>C-C Bond Cleavage in Biosynthesis of 4-Alkyl-L-Proline Precursors of Lincomycin and Anthramycin Cannot Precede C-Methylation</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>3167</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05455-3</pub-id><pub-id pub-id-type="pmid">30093642</pub-id></element-citation></ref><ref id="B101-molecules-27-06387"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hurley</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Elucidation and Formulation of Novel Biosynthetic Pathways Leading to the Pyrrolo[1,4]Benzodiazepine Antibiotics Anthramycin, Tomaymycin, and Sibiromycin</article-title><source>Acc. Chem. Res.</source><year>1980</year><volume>13</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1021/ar50152a003</pub-id></element-citation></ref><ref id="B102-molecules-27-06387"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Chou</surname><given-names>S.</given-names></name>
<name><surname>Khullar</surname><given-names>A.</given-names></name>
<name><surname>Gerratana</surname><given-names>B.</given-names></name>
</person-group><article-title>Cloning and Characterization of the Biosynthetic Gene Cluster for Tomaymycin, an SJG-136 Monomeric Analog</article-title><source>Appl. Environ. Microbiol.</source><year>2009</year><volume>75</volume><fpage>2958</fpage><lpage>2963</lpage><pub-id pub-id-type="doi">10.1128/AEM.02325-08</pub-id><pub-id pub-id-type="pmid">19270147</pub-id></element-citation></ref><ref id="B103-molecules-27-06387"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saha</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Gerratana</surname><given-names>B.</given-names></name>
<name><surname>Rokita</surname><given-names>S.E.</given-names></name>
</person-group><article-title>Identification of the Dioxygenase-Generated Intermediate Formed during Biosynthesis of the Dihydropyrrole Moiety Common to Anthramycin and Sibiromycin</article-title><source>Bioorg. Med. Chem.</source><year>2015</year><volume>23</volume><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2014.12.024</pub-id><pub-id pub-id-type="pmid">25564379</pub-id></element-citation></ref><ref id="B104-molecules-27-06387"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>U.</given-names></name>
</person-group><article-title>Acyl Pentapeptide Lactone Synthesis in Actinomycin-Producing Streptomycetes by Feeding with Structural Analogs of 4-Methyl-3-Hydroxyanthranilic Acid</article-title><source>J. Biol. Chem.</source><year>1984</year><volume>259</volume><fpage>8226</fpage><lpage>8231</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(17)39717-X</pub-id><pub-id pub-id-type="pmid">6203903</pub-id></element-citation></ref><ref id="B105-molecules-27-06387"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matthijs</surname><given-names>S.</given-names></name>
<name><surname>Baysse</surname><given-names>C.</given-names></name>
<name><surname>Koedam</surname><given-names>N.</given-names></name>
<name><surname>Tehrani</surname><given-names>K.A.</given-names></name>
<name><surname>Verheyden</surname><given-names>L.</given-names></name>
<name><surname>Budzikiewicz</surname><given-names>H.</given-names></name>
<name><surname>Sch&#x000e4;fer</surname><given-names>M.</given-names></name>
<name><surname>Hoorelbeke</surname><given-names>B.</given-names></name>
<name><surname>Meyer</surname><given-names>J.-M.</given-names></name>
<name><surname>De Greve</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>The Pseudomonas Siderophore Quinolobactin Is Synthesized from Xanthurenic Acid, an Intermediate of the Kynurenine Pathway: Quinolobactin Siderophore from P. Fluorescens</article-title><source>Mol. Microbiol.</source><year>2004</year><volume>52</volume><fpage>371</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.03999.x</pub-id><pub-id pub-id-type="pmid">15066027</pub-id></element-citation></ref><ref id="B106-molecules-27-06387"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>K.T.</given-names></name>
<name><surname>Kau</surname><given-names>D.</given-names></name>
<name><surname>Gu</surname><given-names>J.-Q.</given-names></name>
<name><surname>Brian</surname><given-names>P.</given-names></name>
<name><surname>Wrigley</surname><given-names>S.K.</given-names></name>
<name><surname>Baltz</surname><given-names>R.H.</given-names></name>
<name><surname>Miao</surname><given-names>V.</given-names></name>
</person-group><article-title>A Glutamic Acid 3-Methyltransferase Encoded by an Accessory Gene Locus Important for Daptomycin Biosynthesis in <italic toggle="yes">Streptomyces roseosporus</italic></article-title><source>Mol. Microbiol.</source><year>2006</year><volume>61</volume><fpage>1294</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05305.x</pub-id><pub-id pub-id-type="pmid">16879412</pub-id></element-citation></ref><ref id="B107-molecules-27-06387"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>Phelan</surname><given-names>V.</given-names></name>
<name><surname>Ntai</surname><given-names>I.</given-names></name>
<name><surname>Farnet</surname><given-names>C.M.</given-names></name>
<name><surname>Zazopoulos</surname><given-names>E.</given-names></name>
<name><surname>Bachmann</surname><given-names>B.O.</given-names></name>
</person-group><article-title>Benzodiazepine Biosynthesis in <italic toggle="yes">Streptomyces refuineus</italic></article-title><source>Chem. Biol.</source><year>2007</year><volume>14</volume><fpage>691</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2007.05.009</pub-id><pub-id pub-id-type="pmid">17584616</pub-id></element-citation></ref><ref id="B108-molecules-27-06387"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giessen</surname><given-names>T.W.</given-names></name>
<name><surname>Kraas</surname><given-names>F.I.</given-names></name>
<name><surname>Marahiel</surname><given-names>M.A.</given-names></name>
</person-group><article-title>A Four-Enzyme Pathway for 3,5-Dihydroxy-4-Methylanthranilic Acid Formation and Incorporation into the Antitumor Antibiotic Sibiromycin</article-title><source>Biochemistry</source><year>2011</year><volume>50</volume><fpage>5680</fpage><lpage>5692</lpage><pub-id pub-id-type="doi">10.1021/bi2006114</pub-id><pub-id pub-id-type="pmid">21612226</pub-id></element-citation></ref><ref id="B109-molecules-27-06387"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scott</surname><given-names>J.D.</given-names></name>
<name><surname>Williams</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Chemistry and Biology of the Tetrahydroisoquinoline Antitumor Antibiotics</article-title><source>Chem. Rev.</source><year>2002</year><volume>102</volume><fpage>1669</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1021/cr010212u</pub-id><pub-id pub-id-type="pmid">11996547</pub-id></element-citation></ref><ref id="B110-molecules-27-06387"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le</surname><given-names>V.H.</given-names></name>
<name><surname>Inai</surname><given-names>M.</given-names></name>
<name><surname>Williams</surname><given-names>R.M.</given-names></name>
<name><surname>Kan</surname><given-names>T.</given-names></name>
</person-group><article-title>Ecteinascidins. A Review of the Chemistry, Biology and Clinical Utility of Potent Tetrahydroisoquinoline Antitumor Antibiotics</article-title><source>Nat. Prod. Rep.</source><year>2015</year><volume>32</volume><fpage>328</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1039/C4NP00051J</pub-id><pub-id pub-id-type="pmid">25273374</pub-id></element-citation></ref><ref id="B111-molecules-27-06387"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lown</surname><given-names>J.W.</given-names></name>
<name><surname>Joshua</surname><given-names>A.V.</given-names></name>
<name><surname>Lee</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Molecular Mechanisms of Binding and Single-Strand Scission of DNA by the Antitumor Antibiotics Saframycins A and C</article-title><source>Biochemistry</source><year>1982</year><volume>21</volume><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1021/bi00532a001</pub-id><pub-id pub-id-type="pmid">7066293</pub-id></element-citation></ref><ref id="B112-molecules-27-06387"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hill</surname><given-names>G.C.</given-names></name>
<name><surname>Remers</surname><given-names>W.A.</given-names></name>
</person-group><article-title>Computer Simulation of the Binding of Saframycin A to d(GATGCATC)<sub>2</sub></article-title><source>J. Med. Chem.</source><year>1991</year><volume>34</volume><fpage>1990</fpage><lpage>1998</lpage><pub-id pub-id-type="doi">10.1021/jm00111a011</pub-id><?supplied-pmid 2066972?><pub-id pub-id-type="pmid">2066972</pub-id></element-citation></ref><ref id="B113-molecules-27-06387"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Wen</surname><given-names>W.-H.</given-names></name>
<name><surname>Pu</surname><given-names>J.-Y.</given-names></name>
<name><surname>Tang</surname><given-names>M.-C.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Peng</surname><given-names>C.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Extracellularly Oxidative Activation and Inactivation of Matured Prodrug for Cryptic Self-Resistance in Naphthyridinomycin Biosynthesis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>11232</fpage><lpage>11237</lpage><pub-id pub-id-type="doi">10.1073/pnas.1800502115</pub-id><?supplied-pmid 30327344?><pub-id pub-id-type="pmid">30327344</pub-id></element-citation></ref><ref id="B114-molecules-27-06387"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wen</surname><given-names>W.-H.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.-Y.</given-names></name>
<name><surname>Yu</surname><given-names>Q.</given-names></name>
<name><surname>Jiang</surname><given-names>C.-C.</given-names></name>
<name><surname>Tang</surname><given-names>M.-C.</given-names></name>
<name><surname>Pu</surname><given-names>J.-Y.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.-L.</given-names></name>
<name><surname>Shi</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Reductive Inactivation of the Hemiaminal Pharmacophore for Resistance against Tetrahydroisoquinoline Antibiotics</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>7085</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-27404-3</pub-id><?supplied-pmid 34873166?><pub-id pub-id-type="pmid">34873166</pub-id></element-citation></ref><ref id="B115-molecules-27-06387"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mikami</surname><given-names>Y.</given-names></name>
<name><surname>Takahashi</surname><given-names>K.</given-names></name>
<name><surname>Yazawa</surname><given-names>K.</given-names></name>
<name><surname>Arai</surname><given-names>T.</given-names></name>
<name><surname>Namikoshi</surname><given-names>M.</given-names></name>
<name><surname>Iwasaki</surname><given-names>S.</given-names></name>
<name><surname>Okuda</surname><given-names>S.</given-names></name>
</person-group><article-title>Biosynthetic Studies on Saframycin A, a Quinone Antitumor Antibiotic Produced by <italic toggle="yes">Streptomyces lavendulae</italic></article-title><source>J. Biol. Chem.</source><year>1985</year><volume>260</volume><fpage>344</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)89738-1</pub-id><pub-id pub-id-type="pmid">3880741</pub-id></element-citation></ref><ref id="B116-molecules-27-06387"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arai</surname><given-names>T.</given-names></name>
<name><surname>Yazawa</surname><given-names>K.</given-names></name>
<name><surname>Takahashi</surname><given-names>K.</given-names></name>
<name><surname>Maeda</surname><given-names>A.</given-names></name>
<name><surname>Mikami</surname><given-names>Y.</given-names></name>
</person-group><article-title>Directed Biosynthesis of New Saframycin Derivatives with Resting Cells of <italic toggle="yes">Streptomyces lavendulae</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>1985</year><volume>28</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1128/AAC.28.1.5</pub-id><?supplied-pmid 3839995?><pub-id pub-id-type="pmid">3839995</pub-id></element-citation></ref><ref id="B117-molecules-27-06387"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>M.-C.</given-names></name>
<name><surname>Fu</surname><given-names>C.-Y.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Characterization of SfmD as a Heme Peroxidase That Catalyzes the Regioselective Hydroxylation of 3-Methyltyrosine to 3-Hydroxy-5-Methyltyrosine in Saframycin A Biosynthesis</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>5112</fpage><lpage>5121</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.306316</pub-id><pub-id pub-id-type="pmid">22187429</pub-id></element-citation></ref><ref id="B118-molecules-27-06387"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>C.-Y.</given-names></name>
<name><surname>Tang</surname><given-names>M.-C.</given-names></name>
<name><surname>Peng</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>Y.-L.</given-names></name>
<name><surname>Liu</surname><given-names>W.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Biosynthesis of 3-Hydroxy-5-Methyl-o-Methyltyrosine in the Saframycin/ Safracin Biosynthetic Pathway</article-title><source>J. Microbiol. Biotechnol.</source><year>2009</year><volume>19</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.4014/jmb.0808.484</pub-id><pub-id pub-id-type="pmid">19494690</pub-id></element-citation></ref><ref id="B119-molecules-27-06387"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koketsu</surname><given-names>K.</given-names></name>
<name><surname>Watanabe</surname><given-names>K.</given-names></name>
<name><surname>Suda</surname><given-names>H.</given-names></name>
<name><surname>Oguri</surname><given-names>H.</given-names></name>
<name><surname>Oikawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Reconstruction of the Saframycin Core Scaffold Defines Dual Pictet-Spengler Mechanisms</article-title><source>Nat. Chem. Biol.</source><year>2010</year><volume>6</volume><fpage>408</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/nchembio.365</pub-id><pub-id pub-id-type="pmid">20453862</pub-id></element-citation></ref><ref id="B120-molecules-27-06387"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>St&#x000f6;ckigt</surname><given-names>J.</given-names></name>
<name><surname>Antonchick</surname><given-names>A.P.</given-names></name>
<name><surname>Wu</surname><given-names>F.</given-names></name>
<name><surname>Waldmann</surname><given-names>H.</given-names></name>
</person-group><article-title>The Pictet-Spengler Reaction in Nature and in Organic Chemistry</article-title><source>Angew. Chem. Int. Ed.</source><year>2011</year><volume>50</volume><fpage>8538</fpage><lpage>8564</lpage><pub-id pub-id-type="doi">10.1002/anie.201008071</pub-id></element-citation></ref><ref id="B121-molecules-27-06387"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>L.-Q.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.-Y.</given-names></name>
<name><surname>Pu</surname><given-names>J.-Y.</given-names></name>
<name><surname>Tang</surname><given-names>M.-C.</given-names></name>
<name><surname>Peng</surname><given-names>C.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
</person-group><article-title>Catalysis of Extracellular Deamination by a FAD-Linked Oxidoreductase after Prodrug Maturation in the Biosynthesis of Saframycin A</article-title><source>Angew. Chem. Int. Ed.</source><year>2017</year><volume>129</volume><fpage>9244</fpage><lpage>9248</lpage><pub-id pub-id-type="doi">10.1002/ange.201704726</pub-id></element-citation></ref><ref id="B122-molecules-27-06387"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gates</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Mechanisms of DNA Damage by Leinamycin</article-title><source>Chem. Res. Toxicol.</source><year>2000</year><volume>13</volume><fpage>953</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1021/tx000089m</pub-id><pub-id pub-id-type="pmid">11080040</pub-id></element-citation></ref><ref id="B123-molecules-27-06387"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fekry</surname><given-names>M.I.</given-names></name>
<name><surname>Szekely</surname><given-names>J.</given-names></name>
<name><surname>Dutta</surname><given-names>S.</given-names></name>
<name><surname>Breydo</surname><given-names>L.</given-names></name>
<name><surname>Zang</surname><given-names>H.</given-names></name>
<name><surname>Gates</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Noncovalent DNA Binding Drives DNA Alkylation by Leinamycin: Evidence That the <italic toggle="yes">Z</italic>, <italic toggle="yes">E</italic> -5-(Thiazol-4-Yl)-Penta-2,4-Dienone Moiety of the Natural Product Serves as an Atypical DNA Intercalator</article-title><source>J. Am. Chem. Soc.</source><year>2011</year><volume>133</volume><fpage>17641</fpage><lpage>17651</lpage><pub-id pub-id-type="doi">10.1021/ja2046149</pub-id><pub-id pub-id-type="pmid">21954957</pub-id></element-citation></ref><ref id="B124-molecules-27-06387"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Asai</surname><given-names>A.</given-names></name>
<name><surname>Hara</surname><given-names>M.</given-names></name>
<name><surname>Kakita</surname><given-names>S.</given-names></name>
<name><surname>Kanda</surname><given-names>Y.</given-names></name>
<name><surname>Yoshida</surname><given-names>M.</given-names></name>
<name><surname>Saito</surname><given-names>H.</given-names></name>
<name><surname>Saitoh</surname><given-names>Y.</given-names></name>
</person-group><article-title>Thiol-Mediated DNA Alkylation by the Novel Antitumor Antibiotic Leinamycin</article-title><source>J. Am. Chem. Soc.</source><year>1996</year><volume>118</volume><fpage>6802</fpage><lpage>6803</lpage><pub-id pub-id-type="doi">10.1021/ja960892w</pub-id></element-citation></ref><ref id="B125-molecules-27-06387"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Breydo</surname><given-names>L.</given-names></name>
<name><surname>Zang</surname><given-names>H.</given-names></name>
<name><surname>Mitra</surname><given-names>K.</given-names></name>
<name><surname>Gates</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Thiol-Independent DNA Alkylation by Leinamycin</article-title><source>J. Am. Chem. Soc.</source><year>2001</year><volume>123</volume><fpage>2060</fpage><lpage>2061</lpage><pub-id pub-id-type="doi">10.1021/ja003309r</pub-id><pub-id pub-id-type="pmid">11456831</pub-id></element-citation></ref><ref id="B126-molecules-27-06387"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>S.-X.</given-names></name>
<name><surname>Yun</surname><given-names>B.-S.</given-names></name>
<name><surname>Ma</surname><given-names>M.</given-names></name>
<name><surname>Basu</surname><given-names>H.S.</given-names></name>
<name><surname>Church</surname><given-names>D.R.</given-names></name>
<name><surname>Ingenhorst</surname><given-names>G.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>D.</given-names></name>
<name><surname>Lohman</surname><given-names>J.R.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<etal/>
</person-group><article-title>Leinamycin E1 Acting as an Anticancer Prodrug Activated by Reactive Oxygen Species</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>8278</fpage><lpage>8283</lpage><pub-id pub-id-type="doi">10.1073/pnas.1506761112</pub-id><pub-id pub-id-type="pmid">26056295</pub-id></element-citation></ref><ref id="B127-molecules-27-06387"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<name><surname>Cheng</surname><given-names>Y.-Q.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Chain Initiation in the Leinamycin-Producing Hybrid Nonribosomal Peptide/Polyketide Synthetase from Streptomyces Atroolivaceus S-140. Discrete, Monofunctional Adenylation Enzyme and Peptidyl Carrier Protein That Directly Load D-Alanine</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>20273</fpage><lpage>20282</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702814200</pub-id><pub-id pub-id-type="pmid">17502372</pub-id></element-citation></ref><ref id="B128-molecules-27-06387"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>Y.-Q.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Type I Polyketide Synthase Requiring a Discrete Acyltransferase for Polyketide Biosynthesis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>3149</fpage><lpage>3154</lpage><pub-id pub-id-type="doi">10.1073/pnas.0537286100</pub-id><pub-id pub-id-type="pmid">12598647</pub-id></element-citation></ref><ref id="B129-molecules-27-06387"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Helfrich</surname><given-names>E.J.N.</given-names></name>
<name><surname>Piel</surname><given-names>J.</given-names></name>
</person-group><article-title>Biosynthesis of Polyketides by Trans-AT Polyketide Synthases</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>231</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1039/C5NP00125K</pub-id><pub-id pub-id-type="pmid">26689670</pub-id></element-citation></ref><ref id="B130-molecules-27-06387"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<name><surname>Cheng</surname><given-names>Y.-Q.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Polyketide Chain Skipping Mechanism in the Biosynthesis of the Hybrid Nonribosomal Peptide&#x02212;Polyketide Antitumor Antibiotic Leinamycin in <italic toggle="yes">Streptomyces atroolivaceus</italic> S-140</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>387</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1021/np050467t</pub-id><pub-id pub-id-type="pmid">16562841</pub-id></element-citation></ref><ref id="B131-molecules-27-06387"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<name><surname>Pan</surname><given-names>G.</given-names></name>
<name><surname>Chang</surname><given-names>C.-Y.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Characterization of the Ketosynthase and Acyl Carrier Protein Domains at the LnmI Nonribosomal Peptide Synthetase&#x02013;Polyketide Synthase Interface for Leinamycin Biosynthesis</article-title><source>Org. Lett.</source><year>2016</year><volume>18</volume><fpage>4288</fpage><lpage>4291</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.6b02033</pub-id><pub-id pub-id-type="pmid">27541042</pub-id></element-citation></ref><ref id="B132-molecules-27-06387"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>Y.-Q.</given-names></name>
<name><surname>Tang</surname><given-names>G.-L.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Identification and Localization of the Gene Cluster Encoding Biosynthesis of the Antitumor Macrolactam Leinamycin in <italic toggle="yes">Streptomyces atroolivaceus</italic> S-140</article-title><source>J. Bacteriol.</source><year>2002</year><volume>184</volume><fpage>7013</fpage><lpage>7024</lpage><pub-id pub-id-type="doi">10.1128/JB.184.24.7013-7024.2002</pub-id><pub-id pub-id-type="pmid">12446651</pub-id></element-citation></ref><ref id="B133-molecules-27-06387"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dunbar</surname><given-names>K.L.</given-names></name>
<name><surname>Scharf</surname><given-names>D.H.</given-names></name>
<name><surname>Litomska</surname><given-names>A.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Enzymatic Carbon&#x02013;Sulfur Bond Formation in Natural Product Biosynthesis</article-title><source>Chem. Rev.</source><year>2017</year><volume>117</volume><fpage>5521</fpage><lpage>5577</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00697</pub-id><pub-id pub-id-type="pmid">28418240</pub-id></element-citation></ref><ref id="B134-molecules-27-06387"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>M.</given-names></name>
<name><surname>Lohman</surname><given-names>J.R.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>C-S Bond Cleavage by a Polyketide Synthase Domain</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>10359</fpage><lpage>10364</lpage><pub-id pub-id-type="doi">10.1073/pnas.1508437112</pub-id><pub-id pub-id-type="pmid">26240335</pub-id></element-citation></ref><ref id="B135-molecules-27-06387"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>S.-X.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
<name><surname>Tang</surname><given-names>G.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Characterization of the <italic toggle="yes">LnmKLM</italic> Genes Unveiling Key Intermediates for &#x003b2;-Alkylation in Leinamycin Biosynthesis</article-title><source>Org. Lett.</source><year>2011</year><volume>13</volume><fpage>498</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1021/ol102838y</pub-id><pub-id pub-id-type="pmid">21192727</pub-id></element-citation></ref><ref id="B136-molecules-27-06387"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meng</surname><given-names>S.</given-names></name>
<name><surname>Steele</surname><given-names>A.D.</given-names></name>
<name><surname>Yan</surname><given-names>W.</given-names></name>
<name><surname>Pan</surname><given-names>G.</given-names></name>
<name><surname>Kalkreuter</surname><given-names>E.</given-names></name>
<name><surname>Liu</surname><given-names>Y.-C.</given-names></name>
<name><surname>Xu</surname><given-names>Z.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Thiocysteine Lyases as Polyketide Synthase Domains Installing Hydropersulfide into Natural Products and a Hydropersulfide Methyltransferase</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>5672</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-25798-8</pub-id><pub-id pub-id-type="pmid">34584078</pub-id></element-citation></ref><ref id="B137-molecules-27-06387"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwong</surname><given-names>T.</given-names></name>
<name><surname>Ma</surname><given-names>M.</given-names></name>
<name><surname>Pan</surname><given-names>G.</given-names></name>
<name><surname>Hindra</surname></name>
<name><surname>Yang</surname><given-names>D.</given-names></name>
<name><surname>Yang</surname><given-names>C.</given-names></name>
<name><surname>Lohman</surname><given-names>J.R.</given-names></name>
<name><surname>Rudolf</surname><given-names>J.D.</given-names></name>
<name><surname>Cleveland</surname><given-names>J.L.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>P450-Catalyzed Tailoring Steps in Leinamycin Biosynthesis Featuring Regio- and Stereoselective Hydroxylations and Substrate Promiscuities</article-title><source>Biochemistry</source><year>2018</year><volume>57</volume><fpage>5005</fpage><lpage>5013</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.8b00623</pub-id><pub-id pub-id-type="pmid">30070831</pub-id></element-citation></ref><ref id="B138-molecules-27-06387"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kharel</surname><given-names>M.K.</given-names></name>
<name><surname>Pahari</surname><given-names>P.</given-names></name>
<name><surname>Shepherd</surname><given-names>M.D.</given-names></name>
<name><surname>Tibrewal</surname><given-names>N.</given-names></name>
<name><surname>Nybo</surname><given-names>S.E.</given-names></name>
<name><surname>Shaaban</surname><given-names>K.A.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>Angucyclines: Biosynthesis, Mode-of-Action, New Natural Products, and Synthesis</article-title><source>Nat. Prod. Rep.</source><year>2012</year><volume>29</volume><fpage>264</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1039/C1NP00068C</pub-id><pub-id pub-id-type="pmid">22186970</pub-id></element-citation></ref><ref id="B139-molecules-27-06387"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.-M.</given-names></name>
<name><surname>Shepherd</surname><given-names>M.D.</given-names></name>
<name><surname>Horn</surname><given-names>J.</given-names></name>
<name><surname>Leggas</surname><given-names>M.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>Enzymatic Methylation and Structure-Activity-Relationship Studies on Polycarcin V, a Gilvocarcin-Type Antitumor Agent</article-title><source>ChemBioChem</source><year>2014</year><volume>15</volume><fpage>2729</fpage><lpage>2735</lpage><pub-id pub-id-type="doi">10.1002/cbic.201402426</pub-id><pub-id pub-id-type="pmid">25366963</pub-id></element-citation></ref><ref id="B140-molecules-27-06387"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McGee</surname><given-names>L.R.</given-names></name>
<name><surname>Misra</surname><given-names>R.</given-names></name>
</person-group><article-title>Gilvocarcin Photobiology. Isolation and Characterization of the DNA Photoadduct</article-title><source>J. Am. Chem. Soc.</source><year>1990</year><volume>112</volume><fpage>2386</fpage><lpage>2389</lpage><pub-id pub-id-type="doi">10.1021/ja00162a046</pub-id></element-citation></ref><ref id="B141-molecules-27-06387"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ueberschaar</surname><given-names>N.</given-names></name>
<name><surname>Xu</surname><given-names>Z.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Mets&#x000e4;-Ketel&#x000e4;</surname><given-names>M.</given-names></name>
<name><surname>Bretschneider</surname><given-names>T.</given-names></name>
<name><surname>Dahse</surname><given-names>H.-M.</given-names></name>
<name><surname>G&#x000f6;rls</surname><given-names>H.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Synthetic Remodeling of the Chartreusin Pathway to Tune Antiproliferative and Antibacterial Activities</article-title><source>J. Am. Chem. Soc.</source><year>2013</year><volume>135</volume><fpage>17408</fpage><lpage>17416</lpage><pub-id pub-id-type="doi">10.1021/ja4080024</pub-id><pub-id pub-id-type="pmid">24143864</pub-id></element-citation></ref><ref id="B142-molecules-27-06387"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fischer</surname><given-names>C.</given-names></name>
<name><surname>Lipata</surname><given-names>F.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>The Complete Gene Cluster of the Antitumor Agent Gilvocarcin V and Its Implication for the Biosynthesis of the Gilvocarcins</article-title><source>J. Am. Chem. Soc.</source><year>2003</year><volume>125</volume><fpage>7818</fpage><lpage>7819</lpage><pub-id pub-id-type="doi">10.1021/ja034781q</pub-id><?supplied-pmid 12822997?><pub-id pub-id-type="pmid">12822997</pub-id></element-citation></ref><ref id="B143-molecules-27-06387"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Fischer</surname><given-names>C.</given-names></name>
<name><surname>Beninga</surname><given-names>C.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>Oxidative Rearrangement Processes in the Biosynthesis of Gilvocarcin V</article-title><source>J. Am. Chem. Soc.</source><year>2004</year><volume>126</volume><fpage>12262</fpage><lpage>12263</lpage><pub-id pub-id-type="doi">10.1021/ja0467521</pub-id><?supplied-pmid 15453748?><pub-id pub-id-type="pmid">15453748</pub-id></element-citation></ref><ref id="B144-molecules-27-06387"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kharel</surname><given-names>M.K.</given-names></name>
<name><surname>Zhu</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>Multi-Oxygenase Complexes of the Gilvocarcin and Jadomycin Biosyntheses</article-title><source>J. Am. Chem. Soc.</source><year>2007</year><volume>129</volume><fpage>3780</fpage><lpage>3781</lpage><pub-id pub-id-type="doi">10.1021/ja0680515</pub-id><?supplied-pmid 17346045?><pub-id pub-id-type="pmid">17346045</pub-id></element-citation></ref><ref id="B145-molecules-27-06387"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kharel</surname><given-names>M.K.</given-names></name>
<name><surname>Nybo</surname><given-names>S.E.</given-names></name>
<name><surname>Shepherd</surname><given-names>M.D.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>Cloning and Characterization of the Ravidomycin and Chrysomycin Biosynthetic Gene Clusters</article-title><source>ChemBioChem</source><year>2010</year><volume>11</volume><fpage>523</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1002/cbic.200900673</pub-id><?supplied-pmid 20140934?><pub-id pub-id-type="pmid">20140934</pub-id></element-citation></ref><ref id="B146-molecules-27-06387"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noinaj</surname><given-names>N.</given-names></name>
<name><surname>Bosserman</surname><given-names>M.A.</given-names></name>
<name><surname>Schickli</surname><given-names>M.A.</given-names></name>
<name><surname>Piszczek</surname><given-names>G.</given-names></name>
<name><surname>Kharel</surname><given-names>M.K.</given-names></name>
<name><surname>Pahari</surname><given-names>P.</given-names></name>
<name><surname>Buchanan</surname><given-names>S.K.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
</person-group><article-title>The Crystal Structure and Mechanism of an Unusual Oxidoreductase, GilR, Involved in Gilvocarcin V Biosynthesis</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>23533</fpage><lpage>23543</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.247833</pub-id><?supplied-pmid 21561854?><pub-id pub-id-type="pmid">21561854</pub-id></element-citation></ref><ref id="B147-molecules-27-06387"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiang</surname><given-names>C.-Y.</given-names></name>
<name><surname>Ohashi</surname><given-names>M.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Deciphering Chemical Logic of Fungal Natural Product Biosynthesis Through Heterologous Expression and Genome Mining</article-title><source>Nat. Prod. Rep.</source><year>2022</year><pub-id pub-id-type="doi">10.1039/D2NP00050D</pub-id><?supplied-pmid 36125308?><pub-id pub-id-type="pmid">36125308</pub-id></element-citation></ref><ref id="B148-molecules-27-06387"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bradley</surname><given-names>N.P.</given-names></name>
<name><surname>Wahl</surname><given-names>K.L.</given-names></name>
<name><surname>Steenwyk</surname><given-names>J.L.</given-names></name>
<name><surname>Rokas</surname><given-names>A.</given-names></name>
<name><surname>Eichman</surname><given-names>B.F.</given-names></name>
</person-group><article-title>Resistance-Guided Mining of Bacterial Genotoxins Defines a Family of DNA Glycosylases</article-title><source>mBio</source><year>2022</year><volume>13</volume><fpage>e0329721</fpage><pub-id pub-id-type="doi">10.1128/mbio.03297-21</pub-id><pub-id pub-id-type="pmid">35311535</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="molecules-27-06387-f001"><label>Figure 1</label><caption><p>Chemical structures of spirocyclopropylcyclohexadienone family compounds.</p></caption><graphic xlink:href="molecules-27-06387-g001" position="float"/></fig><fig position="float" id="molecules-27-06387-f002"><label>Figure 2</label><caption><p>(<bold>A</bold>) DNA modification by YTM, and excision of DNA-drug complex by YtkR2. (<bold>B</bold>) Hydrolysis of the cyclopropyl moiety in YTM and CC-1065 by YtkR2 and C10R6, respectively.</p></caption><graphic xlink:href="molecules-27-06387-g002" position="float"/></fig><fig position="float" id="molecules-27-06387-f003"><label>Figure 3</label><caption><p>Isotopic labelling patterns with serine, methionine, and tyrosine.</p></caption><graphic xlink:href="molecules-27-06387-g003" position="float"/></fig><fig position="float" id="molecules-27-06387-f004"><label>Figure 4</label><caption><p>Proposed biosynthetic pathway of CC-1065.</p></caption><graphic xlink:href="molecules-27-06387-g004" position="float"/></fig><fig position="float" id="molecules-27-06387-f005"><label>Figure 5</label><caption><p>Proposed enzymatic mechanism of the cyclopropane moiety formation catalyzed by C10P and C10Q.</p></caption><graphic xlink:href="molecules-27-06387-g005" position="float"/></fig><fig position="float" id="molecules-27-06387-f006"><label>Figure 6</label><caption><p>(<bold>A</bold>) Chemical structures of pluramycins. (<bold>B</bold>) Alkylation of DNA by hedamycin.</p></caption><graphic xlink:href="molecules-27-06387-g006" position="float"/></fig><fig position="float" id="molecules-27-06387-f007"><label>Figure 7</label><caption><p>Proposed biosynthetic pathway of hedamycin. KS, ketosynthase; KR, ketoreductase; ACP, acyl carrier protein; DH, dehydratase; AT, acyl transferase.</p></caption><graphic xlink:href="molecules-27-06387-g007" position="float"/></fig><fig position="float" id="molecules-27-06387-f008"><label>Figure 8</label><caption><p>(<bold>A</bold>) Chemical structures of trioxacarcin A, LL-D49194&#x003b1;1 and their derivates. (<bold>B</bold>) Alkylation of DNA by trioxacarcins.</p></caption><graphic xlink:href="molecules-27-06387-g008" position="float"/></fig><fig position="float" id="molecules-27-06387-f009"><label>Figure 9</label><caption><p>Proposed biosynthetic pathway of trioxacarcin A and LL-D49194&#x003b1;1. CLF, chain length factor.</p></caption><graphic xlink:href="molecules-27-06387-g009" position="float"/></fig><fig position="float" id="molecules-27-06387-f010"><label>Figure 10</label><caption><p>(<bold>A</bold>) Chemical structures of mitomycins. (<bold>B</bold>) Proposed mechanism of DNA cross-linking by mitomycin C and FR-900482.</p></caption><graphic xlink:href="molecules-27-06387-g010" position="float"/></fig><fig position="float" id="molecules-27-06387-f011"><label>Figure 11</label><caption><p>Proposed biosynthetic pathway of mitomycins.</p></caption><graphic xlink:href="molecules-27-06387-g011" position="float"/></fig><fig position="float" id="molecules-27-06387-f012"><label>Figure 12</label><caption><p>Proposed mechanism of DNA cross-linking by azinomycins.</p></caption><graphic xlink:href="molecules-27-06387-g012" position="float"/></fig><fig position="float" id="molecules-27-06387-f013"><label>Figure 13</label><caption><p>Origins of azinomycins revealed by isotopic labelling experiments.</p></caption><graphic xlink:href="molecules-27-06387-g013" position="float"/></fig><fig position="float" id="molecules-27-06387-f014"><label>Figure 14</label><caption><p>Proposed biosynthetic pathway of azinomycins. PCP, peptidyl carrier protein; A, adenylation; C, condensation; RE, reduction. Proposed pathway of constructing 3-methoxy-5-methyl-NPA moiety (<bold>A</bold>), epoxy intermediate (<bold>B</bold>), azabicyclic fragment (<bold>C</bold>), and incorporating building blocks (<bold>D</bold>).</p></caption><graphic xlink:href="molecules-27-06387-g014" position="float"/></fig><fig position="float" id="molecules-27-06387-f015"><label>Figure 15</label><caption><p>(<bold>A</bold>) Origins of pyrrolobenzodiazepines revealed by isotopic labeling experiments. (<bold>B</bold>) Chemical structure of SJG-136. (<bold>C</bold>) Proposed mechanism of DNA alkylating by pyrrolobenzodiazapines.</p></caption><graphic xlink:href="molecules-27-06387-g015" position="float"/></fig><fig position="float" id="molecules-27-06387-f016"><label>Figure 16</label><caption><p>Proposed biosynthetic pathway of dihydropyrrole moieties (<bold>A</bold>), anthranilic acid moieties (<bold>B</bold>), and assembling two building blocks (<bold>C</bold>).</p></caption><graphic xlink:href="molecules-27-06387-g016" position="float"/></fig><fig position="float" id="molecules-27-06387-f017"><label>Figure 17</label><caption><p>(<bold>A</bold>) Chemical structures of tetrahydroisoquinoline family. (<bold>B</bold>) Proposed mechanism of DNA alkylating by saframycin A.</p></caption><graphic xlink:href="molecules-27-06387-g017" position="float"/></fig><fig position="float" id="molecules-27-06387-f018"><label>Figure 18</label><caption><p>Origins of saframycins revealed by isotopic precursors labeling experiments.</p></caption><graphic xlink:href="molecules-27-06387-g018" position="float"/></fig><fig position="float" id="molecules-27-06387-f019"><label>Figure 19</label><caption><p>Proposed biosynthetic pathway of quinone moiety (<bold>A</bold>) and forming the skeleton of saframycins (<bold>B</bold>).</p></caption><graphic xlink:href="molecules-27-06387-g019" position="float"/></fig><fig position="float" id="molecules-27-06387-f020"><label>Figure 20</label><caption><p>Post-modification of saframycins.</p></caption><graphic xlink:href="molecules-27-06387-g020" position="float"/></fig><fig position="float" id="molecules-27-06387-f021"><label>Figure 21</label><caption><p>Proposed mechanisms of DNA alkylating by leinamycin and leinamycin E1.</p></caption><graphic xlink:href="molecules-27-06387-g021" position="float"/></fig><fig position="float" id="molecules-27-06387-f022"><label>Figure 22</label><caption><p>Proposed biosynthetic pathway of leinamycin. CP, carrier protein; CY, condensation/cyclization; MT, transferase; ER, enoyl reductase; TE, thioesterase; DUF, the domain of unknown function; SH, PLP-dependent cysteine lyase domain.</p></caption><graphic xlink:href="molecules-27-06387-g022" position="float"/></fig><fig position="float" id="molecules-27-06387-f023"><label>Figure 23</label><caption><p>(<bold>A</bold>) Chemical structure of gilvocarcin V, chrysomycin A, and ravidomycin. (<bold>B</bold>) Mode of action of vinyl-containing gilvocarcin-type natural products.</p></caption><graphic xlink:href="molecules-27-06387-g023" position="float"/></fig><fig position="float" id="molecules-27-06387-f024"><label>Figure 24</label><caption><p>Proposed biosynthetic pathway of gilvocarcin V.</p></caption><graphic xlink:href="molecules-27-06387-g024" position="float"/></fig></floats-group></article>